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Enterococcus faecalis is a Gram-positive commensal bacterium forming diplococci/short 
chains that can also be an opportunistic pathogen. Some infections caused by E. faecalis such 
as endocarditis and bacteraemia can be life-threatening and difficult to treat due the resistance 
of this organism to several classes of antibiotics. Recent data revealed that the morphology of 
E. faecalis is an important factor for pathogenesis. Whilst strains forming diplococci or short 
chains can evade phagocytes and cause lethality in the zebrafish model of infection, isogenic 
derivatives forming long cell chains are more susceptible to phagocyte uptake and become 
avirulent. The enzyme dedicated to septum cleavage in E. faecalis, N-acetylglucosaminidase 
AtlA therefore has a key role during pathogenesis. The aim of this project was to identify 
genes involved in the control of AtlA activity during cell division. We used two distinct 
phenotypic screens to isolate spontaneous and transposon mutants impaired in septum 
cleavage. Our results indicate that several mechanisms ensure spatial and temporal control of 
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1.1. Enterococcus faecalis 
1.1.1. Discovery of enterococci as a novel bacterial genus 
The first description of "Enterococcus” was reported by Thiercelin in a French publication in 
1899 (Thiercelin, 1899).  He isolated a bacterium found in large numbers from human faeces 
and named it as “Enterocoque”. In this publication, Thiercelin described a gram-positive 
organism with an ovoid shape forming diplococci or short chains. 
Virulence tests revealed that mice were very susceptible to infections by this germ whereas 
guinea pigs were resistant to infections. Rabbits were only killed when injected in high doses. 
Interestingly, Thiercelin mentions that the “Enterocoque” he described was similar to others 
isolated from patients with enteritis, appendicitis, and meningitis. It is therefore tempting to 
assume that the article published by Thiercelin is the first description of the opportunistic 
pathogen that we know now as Enterococcus faecalis. 
At the beginning of the 19th century, numerous publications described Gram-positive 
organisms forming diplococci or short chains isolated from infected patients or from various 
biological samples (pus, saliva, faeces, etc.). Some of these organisms were referred to as 
Streptococcus faecalis and it is difficult to know whether or not they corresponded to what 
was later defined as Enterococcus faecalis. In 1905, it was proposed that antistreptococcic 
sera might help to discriminate between Streptococci and apply a suitable treatment (Gordon, 
1905). 
This work highlighted the diversity of the streptococcus group and the need to better classify 
them, thus defining ‘‘Strepto-biology’’ (Gordon, 1905). Nine distinct properties were defined 
to differentiate streptococci (Gordon, 1905) based on (i) the clotting of litmus milk; (ii) the 
reduction of neutral red broth during anaerobic incubation; (iii-ix) the production of an acid 
reaction aerobically when bacteria are cultivated in slightly alkaline broth containing 1%(w/v) 
of saccharose, lactose, raffinose, inulin, salicin, coniferin or mannite (Gordon, 1905). 
 
Despite data from the literature indicating that organisms closely related to S. faecalis have 
unique properties amongst streptococci, the genus Enterococcus was only formally identified 






Enterococci cells are ovoid and mostly arranged in pairs (diplococci) or short chains typically 
containing 4 to 6 cells (Murray, 1990; Hardie and Whiley, 1997). Enterococci are non-
sporulating bacteria and the vast majority of species are non-motile with a few exceptions 
(e.g., E. gallinarum and E. casseliflavus) (Byappanahalli et al., 2012) (Fig. 1A and B). 
Most enterococci form white/cream colonies on agar plates except E. sulfureus, E. 
casseliflavus, and E. mundtii which produce yellow pigments (Witte, 2003). E. faecalis 
colonies appear dome-shaped with entire edges, getting flatter after prolonged incubations 
(Fig. 1C). 
 
     
Figure 1. Phenotype of E. faecalis cells and colonies (A), optical light microscopy of E. faecalis 
cells after Gram-staining. (B), scanning electron micrograph (SEM) of enterococci grown in liquid 
media showing the oval cell shape and the formation of diplococci. (C), colonies of E. faecalis grown 
on blood agar plate after cultivation for 24 hours under aerobic conditions at 37°C (colonies are non-
haemolytic). [Reference: http://www.bacteriainphotos.com/bacteria-photo-gallery.html]. 
 
 
1.1.3. Distinctive metabolic and phenotypic properties 
Like streptococci, enterococci are aerotolerant anaerobes. They do not use oxygen as an 
electron acceptor. They are homofermentative, predominantly producing lactic acid from 
glucose. Their growth is generally increased in a CO2-enriched environment. Enterococci 
most often appear non-haemolytic (gamma-haemolytic type) but some strains are alpha- or 
more rarely beta-haemolytic, displaying differential activities towards different types of 
erythrocytes. For example, it was reported that in the case of E. faecalis horse red blood cells 




Virulent V583 E. faecalis strain produces a cytolysin with beta-haemolytic activity encoded 
by a plasmid that found on a pathogenicity island (Shankar et al., 2002).  Like streptococci 
and unlike micrococci (such as Staphylococcus aureus), enterococci are catalase-negative but 
may appear weakly positive for this activity in the presence of heme. This cofactor is required 
for the expression of the gene katA encoding this enzyme, which has been considered as a 
pseudogene for this reason (Frankenberg et al., 2002) . Enterococci can be distinguished from 
streptococci based on their antigenic properties. The extraction of cell wall antigens allows 
the definition of several agglutination groups (Lancefield groups A-V) in the presence of 
specific antibodies (Lancefield, 1933).. 
Group D contains enterococci and a limited number of streptococci including Streptococcus 
bovis and Streptococcus gallolyticus. The distinction between enterococci and streptococci 
belonging to the Lancefield group D requires other specific tests. These include the 
colurimetric detection of L-pyrrolidonyl-beta-naphthylamide hydrolysis by an aminopeptidase 
enzyme (Bosley et al., 1983) or the hydrolysis of aesculine in the presence of bile salts or 
growth in the presence of 0.05% potassium tellurite. Growth on media containing tellurite 
leads to the formation of black colonies. This test is particularly suitable to identify E. faecalis 
as other enterococci are generally inhibited by tellurite (Facklam and Collins, 1989). 
Other metabolic properties can be used to identify enterococci. They essentially rely on sugar 
fermentation profiles (mannitol, sorbitol, L-arabinose, D-raffinose, sucrose, lactose), 
enzymatic activities (such as arginine hydrolysis), growth at defined temperatures or in the 
presence of bile salts (Fertally and Facklam, 1987; Klein, 2003). Identification galleries are 
commercially available. One example is shown in (Fig. 2). Some compounds allow the 
discrimination between enterococci. For example, E. faecalis strongly reduces 
triphenyltetrazolium-chloride (TTC) and produces bright red colony on a medium with TTC, 
whereas E. faecium weakly reduce TTC, forming pale pink colonies (Reuter, 1992). 
Pre-formulated media are now available to specifically allow the growth of enterococci. 
Aesculin-bile-azide medium (ABA, in its commercial formulation called Enterococcosel 
ECS), Citrate azide tween carbonate agar (CATC), Crystal violet azide agar (KA), Kanamycin 
aesculin azide agar (KAA), Slanetz and Bartley medium (ME), Streptococcus selective agar 
(ScS) and Thallous acetate tetrazolium glucose agar (TITG) (Reuter, 1992). 
Enterococci do not require adenosine, guanosine, uracil, or thymine and can be grown in a 
synthetic medium as long as it is supplemented with several amino acids and vitamins. It has 




Specific requirements are not known and synthetic media described usually contain nicotinic 
acid, pantothenic acid, biotin, pyridoxine, riboflavin, and sometimes folic acid (Murray et al., 
1993). Four amino acids (histidine, isoleucine, methionine, and tryptophan) are essential for 
several E. faecalis strains whilst other amino acids are often required to promote growth or to 
increase growth rate. Amino-acid requirements are variable depending on the strain 
considered. For example E. faecalis strains ATCC 29212 and JH2-2 are auxotroph for 
arginine, glutamate, glycine, leucine and valine whereas OG1 strain grows poorly without 
these amino acids (Murray et al., 1993); depletion of cysteine, serine, or threonine has no 
effect on JH2-2 and OG1RF strains whereas it affects growth of E. faecalis ATCC 29212 
(Murray et al., 1993). 
 
 
Figure 2. E. faecalis identification using a commercially available gallery based on colorimetric 
tests (STREPTOtest 24, ErbaLachema). The metabolic assays are as follows: line 1, detection of N-
acetyl-N-glucosaminidase, L-leucin-aminopeptidase, β-mannosidase, β-glucuronidase, β-glucosidase, 
β-galactosidase, α-galactosidase and phosphatase activities; lane 2, detection of esculin hydrolysis, 
inulin, mannitol, sorbitol, melibiose, ribose, lactose and pullulan fermentation;  Line 3, arginine 
dihydrolase activity, Growth in 6.5% NaCl, α-methylglucosidase activity, tagatose, maltose, raffinose, 




A typical strategy used to identify enterococci is described in (Fig. 3). It combines several 
identification criteria (antigenic properties, growth conditions, and fermentation profile). 
 






1.1.4. Molecular Identification  
DNA-DNA and DNA-rRNA hybridization methods have been used to group several species 
from the Lancefield group D in a novel genus called “Enterococcus” (Schleifer and Kilpper-
Bälz, 1984). Schleifer and Kilpper-Bälz’s results clearly revealed that within the Enterococcus 
group, two species (formerly Streptococcus faecalis and Streptococcus faecium, renamed E. 
faecalis and E. faecium) showed only limited DNA homology. As pointed out by the authors, 
this distinction was supported by distinct peptidoglycan composition (E. faecalis containing 
L-Ala instead of D-Asp in PG crossbridges) see chapter 1.2. 
 
As an alternative to 16S rDNA sequencing, Enterococcal strains can be identified by 
sequencing a 438-bp-long PCR fragment internal to the sodA gene encoding the manganese-
dependent superoxide dismutase amplified with degenerate primers (Poyart et al., 2002). The 
sodA gene represents a more discriminative target sequence than 16S rRNA gene to 
differentiate enterococci. 
 
Epidemiologic studies are particularly important to identify clinical isolates responsible for 
hospital-acquired infections. Identification of E. faecalis is possible using multilocus 
sequence typing (MLST) to define related strains forming clonal complexes (Ruiz-Garbajosa 
et al., 2006), some of which defining High Risk Enterococcal Clonal Complexes (HiRECC 
(Leavis et al., 2006). 
 
1.1.5. Habitat 
Most enterococci are commensal bacteria frequently found in the gastro-intestinal tract (GIT) 
of human, mammals, insects or birds (Fig. 4) and are frequently isolated from faeces. Due to 
their capacity to grow and resist in a wide range of conditions, they are frequently isolated 
from plants, soil, wastewater or fermented food or dairy products that they can contaminated 
(Murray, 1990). Two major species, E. faecalis, and E. faecium are isolated from human 
faeces. E. faecalis is one of the first organisms to colonize newborns (Adlerberth and Wold, 
2009) but although this organism can reach concentrations as high as 107colony-forming units 






Figure 4. Distribution of enterococci in different hosts. The dendrogram shows phylogenic 
relationships. The sources of isolation are indicated for each species. A simplified food chain is 





1.1.6. Genomic data 
The genome of E. faecalis V583 was the first genome sequence published (Paulsen et al., 
2003). This strain is the first clinical isolate resistant to vancomycin isolated in the United 
States. The E. faecalis V583 genome contains one chromosome (3.2Mbp) encoding 3337 
predicted proteins, and three plasmids pTEF1, pTEF2 and pTEF3 of 66.3kbp, 57.7 kbp and 
18.0 kbp, respectively (Paulsen et al., 2003). 
 
The genome of E. faecalis V583 is characterised by the presence of mobile DNA (38 insertion 
sequences), seven prophages, integrated plasmid genes, and a large pathogenicity island 
corresponding to an integrative transposon. V583 genome also encodes a vancomycin-
resistance mechanism. Altogether, mobile and foreign DNA represents approximately a 
quarter of the genome (Paulsen et al., 2003). The description of E. faecalis V583 genome 
revealed the genomic fluidity in this bacterium and explained the capacity of this particular 
strain to cause hospital-acquired infections. It is interesting to note that E. faecalis V583 
genome encodes 134 putative surface-exposed proteins that may be associated with 
colonization or virulence. 
 
The availability of the V583 genome has allowed performing comparative genomic 
hybridization experiments to define the minimal core genome of E. faecalis. Two independent 
studies reported that the core genome of E. faecalis contains 2057 genes (McBride et al., 
2007) and 2092 genes (Lepage et al., 2006). 
 
Recent studies revealed that unlike in E. faecium, a limited genetic diversity is observed 
amongst E. faecalis strains (Palmer et al., 2012). Although the shared gene content varies 
between species (from 70.9 to 96.5%), the average nucleotide identity (ANI) is extremely 
high (99.5%) amongst shared genes (Palmer et al., 2012). More pronounced differences were 
reported between E. faecium genomes, reflecting the existence of two distant clades with 93.9 
to 95.6% ANI. These values overlap an ANI species line of 94 to 95%. 
 
1.1.7. Resistance to stress 
Enterococci can survive in a wide range of harsh conditions. E. faecalis has an optimum 
growth temperature of 35°C, but it can grow from 10 to 45°C (Sherman, 1937) and between 
pH 4.0-10.0. E. faecalis is resistant to high salt concentrations. Growth in the presence of 
6.5% (m/v) NaCl is sometimes used as a discriminant growth condition (Facklam, 1973). 
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The resistance to various stresses has been reported (Rince et al., 2000). These include high 
osmolarity, heat, ethanol treatment; exposure to heavy metals, sodium hypochloride; 
hydrogen peroxide, sodium dodecyl sulfate (SDS; 0.01%) and detergents as well as pH 4.8 or 
10.5. The ability to resist such harsh conditions is associated with a complex network of two-
component systems (Hancock and Perego, 2002) and transcriptional regulators which allow 
the expression of several proteins called Gsp (General stress proteins) (Rince et al., 2000). An 
extra cytoplasmic sigma factor called sigma V belonging to the LysR family has been 
identified in E. faecalis and shown to coordinate resistance to acid stress, ethanol treatments 
and heat shock (Benachour et al., 2005). 
 
1.1.8. Pathogenesis of E. faecalis 
1.1.8.1. Infections caused by E. faecalis 
Enterococci are one of most common organisms causing hospital-acquired infections (HAI). 
A recent survey of HAI from the CDC’s National Healthcare Safety Network identified 
enterococcal species as the second cause of infections after S. aureus (Sievert et al., 2013). E. 
faecalis and E. faecium accounted for 51% and 21% of these strains. Towards the end of the 
1980s, enterococcal infections were essentially caused by E. faecalis (Murray, 1990), but it 
appears that E. faecium is now more prevalent. Enterococcal infection occurs mostly in 
elderly, in immunocompromised patients or following an antibiotic treatment causing an 
imbalance of the normal microbiota. 
 
1.1.8.2 E. faecalis virulence factors 
Some pathogens like S. aureus produce a multitude of potent virulence factors and rely on 
several mechanisms to escape host defences. Instead, E. faecalis produces several 
“opportunism factors” which altogether enable this bacterium to cause infections. These 
factors are described below: 
(i) Secreted factors: Two proteases, the gelatinase GelE and the serine protease SprE are 
secreted by several E. faecalis strains. GelE has been shown to contribute to tissue 
damage by degrading proteins from the extracellular matrix such as fibrin (Waters et al., 
2003; Thurlow et al., 2010). Some E. faecalis strains also produce a cytolysin encoded on 
a plasmid that can integrate on the chromosome in a pathogenicity island (Coburn and 




(ii) Cell wall polymers: Three polymers covalently bound to peptidoglycan have been 
reported in E. faecalis (see paragraph 1.2.2.). The capsule has been shown to prevent 
complement-mediated opsonophagocytosis (Thurlow et al., 2009). The enterococcal 
polysaccharide antigen (Epa) is also contributing to E. faecalis resistance to innate 
immunity (Prajsnar et al., 2013; Teng et al., 2002). The third type of wall-associated 
polymers corresponds to teichoic acids. They have also been shown to confer resistance 
to complement-mediated opsonophagocytosis (Geiss-Liebisch et al., 2012). 
 
(iii) Pili: All E. faecalis strains have a chromosomal locus called ebp (endocarditis and 
biofilm associated pili) encoding pili. These structures were shown to contribute to 
virulence in several infection models including the rat endocarditis model (Nallapareddy 
et al., 2006) and the mice urinary tract infection model (Kemp et al., 2007). Another 
locus named bee (biofilm enhancer in Enterococcus) has been proposed to encode pili but 
it is only present in a very limited number of clinical isolates (approximately 1%)  
(Schluter et al., 2009) 
 
(iv) Adhesins: E. faecalis produces several proteins which contribute to the interaction 
with the host. The aggregation substance (AS), encoded by the plasmidic pgrB gene, is 
covalently bound to peptidoglycan. It contains a tripeptide arg-gly-asp (RGD) that has 
been proposed to contribute to the binding to host integrins (Chuang et al., 2009). The 
aggregation substance also binds to lipoteichoic acids of recipient cells to promote 
conjugation (Waters et al., 2004). The V583 genome encodes seventeen Microbial 
Surface Component Recognition Adhesins for the Microbial Matrix (MSCRAMMs) 
potentially involved in the binding to host molecules. These adhesins include Ace (Rich 
et al., 1999) that binds to collagen and Esp, which is also involved in the formation of 
biofilms (Shankar et al., 2001; Tendolkar et al., 2005). 
 
1.1.8.3. Experimental infection models 
To study the wide range of infections caused by E. faecalis, several infection models have 
been described. Invertebrate models of infection include the wax moth Galleria mellonella 
and the bacteriovorous nematode Caenorhabditis elegans. G. mellonella has an innate 
immune system producing phagocytes and effectors such as lysozyme and antimicrobial 




Vertebrate models of infections have been described in mice, rats, rabbits and more recently 
zebrafish. Depending on the type of infection studied, one model is preferred over the others. 
For example, rabbits and rats are used to study endocarditis (Dube et al., 2012; Haller et al., 
2014) whereas mice are preferred to study urinary tract infections or bacteraemia (Singh et al., 
2009; Teng et al., 2009). Recently, a zebrafish model of infection has been described 
(Prajsnar et al., 2013). Thanks to the transparency of zebrafish larvae, this model allows to 
follow the infection process using fluorescent bacteria. 
 
1.1.9. Resistance to antibiotics 
E. faecalis is intrinsically resistant to several antimicrobial agents and can also acquire 
resistance to a wide range of other antibiotics. As a consequence, infections caused by this 
nosocomial pathogen can be difficult to treat. 
 
1.1.9.1. Resistance to β-lactams 
β-lactams inhibit the enzymes called D,D-transpeptidases or penicillin-binding proteins 
(PBPs) that polymerise peptidoglycan, the essential component of the cell envelope (see 
paragraph 1.2.). E. faecalis produces PBP5, an enzyme with low affinity for cephalosporins. 
As a result, this bacterium is intrinsically resistant to these antibiotics and can grow in the 
presence of high concentrations (up to 1000µg/mL; (Arbeloa et al., 2004). E. faecalis can also 
acquire high resistance to penicillin by overexpression of PBP5 (Duez et al., 2001) or 
acquisition of β-lactamase genes that inactivate β-lactams (Murray and Mederski-Samaroj, 
1983). Although this is a rare mechanism of resistance, it has been suggested that 
enterococcal beta-lactamase genes can be transferred from staphylococci to enterococci 
(Bonafede et al., 1997). 
 
1.1.9.2. Resistance to glycopeptides 
The first vancomycin-resistant clinically enterococcal isolate was reported in Europe in 1988. 
Similar strain was later identified in United States. Subsequently, vancomycin-resistant 
enterococci became abundant in hospitals in several countries (Courvalin, 2006). This 
mechanism of resistance has been extensively studied in E. faecalis. Vancomycin-Resistant 





Vancomycin binds non-covalently to the D-Ala-D-Ala extremity of the peptidoglycan 
precursors and inhibits the activity of PBPs by steric hindrance (Courvalin, 2006). Several 
types of resistance have been described (VanA to VanG) based on the levels of resistance to 
vancomycin and teicoplanin. The van genes are often carried on a mobile element such as the 
vancomycin-resistance vanB locus on the conjugative transposon Tn1549 (Garnier et al., 
2000). Collectively, van genes contribute to modify the peptidoglycan peptide stem so that 
glycopeptide affinity is reduced. The substitution of the C-terminal D-Ala residue by D-
lactate (D-Lac) reduces the affinity of vancomycin for the peptide stems by a factor 1000 
(Fig. 5). 
 
Figure 5. Interaction of vancomycin with peptidoglycan peptide stems. Vancomycin establishes  
five hydrogen bonds with the acyl-D-Ala-D-Ala terminus of peptidoglycan chains and their 
precursors. Resistance results from the loss of the amide group in acyl-D-Ala-D-Lactate resulting in 
loss of one hydrogen bond (Wright, 2011). 
 
 
1.1.9.3. Resistance to antibiotics targeting protein synthesis 
Enterococci are intrinsically resistant to aminoglycosides, macrolides, lincosamides and 
streptogramins. These antibiotics all bind to the 30S or the 50S subunits of the bacterial 
ribosome, thereby inhibiting protein synthesis. This leads to cell growth arrest and then cell 
death. 
Resistance to antibiotics inhibiting protein synthesis involves a wide range of mechanisms, 
some of which occur synergistically to confer very high levels of resistance. Aminoglycosides 
resistance is primarily due to the fact that enterococci are impermeable to these antibiotics so 
that they cannot reach their cytoplasmic targets (Zimmermann et al., 1971). 
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Efflux mechanisms have been reported for streptogramins, lincosamides and tetracyclines 
(Singh et al., 2002). 
In addition to these mechanisms conferring intrinsic resistance, E. faecalis can also acquire 
genes that modifying antibiotics such as (phosphotransferases, nucleotidyltransferases or 
acetyltransferases; (Ramirez and Tolmasky, 2010) that inactivate the drugs as well as 
enzymes able to modify the ribosomes. This is the case of the erm genes products dimethylate 
an adenine in the 23S rRNA (Weisblum, 1995) giving cross-resistance to macrolides, 
lincosamides and group B streptogramins having overlapping binding sites on the ribosome 
(MLSB phenotype). 
 
1.1.9.4. Resistance to antibiotics targeting DNA metabolism 
Quinolones are rarely used to treat enterococcal infections as enterococci show low levels of 
intrinsic resistance. They can also acquire higher levels of resistance. A study of 322 clinical 
enterococcal isolates revealed that none were susceptible to the frequently-used quinolone, 
ciprofloxacin (Hallgren et al., 2001). Mechanisms of resistance are not fully characterised in 
enterococci but the E. faecalis qnr gene was proposed to confer moderate resistance (Arsene 
and Leclercq, 2007). 
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1.2. The cell wall of Gram-positive bacteria 
In gram-positive bacteria, the cell envelope is composed of the cell wall and the cytoplasmic 
membrane. It also contains a space between the cytoplasmic membrane and peptidoglycan 
defined as ‘‘periplasm’’, by analogy with Gram-negative bacteria, which possess an outer 
membrane. The bacterial cell wall is mainly composed of a giant molecule called 
peptidoglycan (PG) or murein. In Gram-positive bacteria, the PG is the major component of 
their cell wall which is responsible for the mechanical resistance to osmotic stresses and 
maintenance the shape of the bacterium (Vollmer and Bertsche, 2008). PG is also used as 
scaffold to display protein such as S-layer protein and polymers such as teichoic acid or 
capsules (Fig. 6) (Silhavy et al., 2010). Lipoteichoic acids covalently attached to the 
cytoplasmic membrane are also embedded in the cell wall; these polymers will not be 
described in this introduction. 
 
 
Figure 6. Schematic organisation of the bacterial cell envelope in Gram-positive bacteria. The 
cell envelope is composed of the cell wall and the cytoplasmic membrane. The cell wall contains S-
layer proteins, teichoic acids, proteins, polysaccharides, and peptidoglycan. Lipoteichoic acids are 
embedded in the cell wall but attached to the cytoplasmic membrane. 
 
 
1.2.1. Peptidoglycan (PG) 
Peptidoglycan is a heteropolymer made of glycan strands that are cross-linked by short 
peptides. It has properties unique to the bacterial kingdom and represents therefore an ideal 
target for antibiotics. Several antibiotics widely used to treat infection including β-lactams 




1.2.1.1. Structure and composition of peptidoglycan 
PG consists of two parts: (i) glycan strands, composed of alternating N-acetylglucosamine 
(GlcNAc) and N-acetylmuramic Acid (MurNAc) residues, which are, linked together by β-
(1,4) glycosidic bonds and (ii) peptide stems, composed of L- and D-amino acids. In most 
Gram-positive bacteria the peptide stem is [L-Ala-γ-D-Gln-DAA-D-Ala-D-Ala], where DAA 
is a diamino acid, usually L-Lysine or meso-diaminopimelic acid (m-DAP). The peptide stem 
is attached to the lactoyl group of the MurNAc residues (van Heijenoort, 2001; Vollmer and 








































Figure 7. Structure of the Gram-positive peptidoglycan (PG). PG consists of glycan chains, cell 
wall peptides, and cross-bridges. Glycan chains are composed of the repeating disaccharide GlcNAc-
MurNAc. The composition of the pentapeptide stem linked to the lactyl group of the MurNAc is most 
often L-Ala-D-iGln-DAA-D-Ala-D-Ala, where DAA represents a diamino acid such as L-Lysine or 
meso-diaminopimelic acid. The peptide chains can be substituted by lateral chains of variable length 




1.2.1.1.1. Glycan strands 
The composition of the glycan strands is extremely conserved in bacteria (always made of 
GlcNAc and MurNAc) (Beeby et al., 2013) but their length differs between species and 
several modifications have been described  (Vollmer, 2008). 
1.2.1.1.1.1. Glycan chain length 
The length of the glycan strands is heterogeneous within a given bacterial species and the 
average length varies from one bacterium to another. For example, S. aureus has short chains 
(5-20 disaccharides) (Wheeler et al., 2011) whereas Bacillus subtilis has long glycan chains 
(>100 disaccharides) (Hayhurst et al., 2008). The average length of the glycan strands is not 
related to the thickness of the peptidoglycan layers (Vollmer and Bertsche, 2008). 
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The average length of the glycan strands can be determined by different methods: 
1- Gel filtration after labelling of the glycan stands with radioactive GlcNAc. 
2- Chemical reduction which specifically labels the residues at the end of the chain. 
Via method is based on the quantification of the ratio between reduced and non-reduced 
hexosamine residues (Harz et al., 1990). 
3-  Via the enzymatic addition of radiolabeled galactosamine residues. This method is 
based on the quantification of the galactosamine residues at the end of the glycan chain 
(Schindler et al., 1976). Individual glycan strands of specific lengths can be seprated analysed 
by HPLC. This method involves three steps: the release of the glycan strands using an 
amidase (an enzyme cleaving between glycan chains and peptide stems); purification of the 
glycan strands by ion exchange chromatography; and finally separation of the glycan strands 
via reverse phase HPLC (Harz et al., 1990). 
 
1.2.1.1.1.2. Glycan chain modifications 
Several modifications of the glycan strands have been described (Fig. 8): (i) the addition of 
polymers such as teichoic acids to the hydroxyl group on C6 of MurNAc; (ii) O-acetylation of 
GlcNAc or MurNAc residues on the C6 position, a modification that prevents hydrolysis by 
some autolysins such as lysozyme. The enzymes involved in PG O-acetylation (O-
acetyltransferases) have been identified in several bacteria (Bera et al., 2005; Hebert et al., 
2007); (iii) de-N-acetylation the Mur-NAC or GlcNAc residues. The enzymes involved in PG 
de-N-acetylation are O-acetyl peptidoglycan esterases (APEs) (Vollmer, 2008)  and have been 
described in several bacteria (Benachour et al., 2012; Boneca et al., 2007; Vollmer and 
Tomasz, 2000); (iv) N-glycolylation in some mycobacteria  (Raymond et al., 2005) or the 










1.2.1.1.2. Peptide stems 
In PG precursors, the lactoyl group of each MurNAc is substituted by the pentapeptide stem. 
Unlike proteins, made exclusively of L-amino acids, PG peptide stems contain D-amino 
acids. In the majority of Gram-positive bacteria, these amino acids are: L-Alanine, γ-D-
Glutamic acid, L-Lysine or meso-diaminopimelic acid, D-Alanine and D-Alanine. Several 
modifications of these amino acids have been reported (Vollmer and Bertsche, 2008) and are 
summarised (table 1). In Gram-positive cocci, the peptide stem contains lateral chains on the 
residue at position 3. Another source of variation is related to the bond between peptide stems  
(van Heijenoort, 2001). 
 
1.2.1.1.2.1. Variation in peptide stem composition 
The amino acid in position 1 is extremely conserved, and is L-Ala in the vast majority of 
Gram-positive bacteria. In position 2, a γ-D-Glu residue is always present on the PG 
precursors, but can be amidated (Gln) (Vollmer and Bertsche, 2008). A diamino acid is found 
in position 3; it can be m-DAP or L-Lysine in most gram positive bacteria, but it can be L-
Homoserine in Corynebacterium poinsettiae (table 1). In position 4, a D-Ala is always 
present. Finally, the residue in position 5 (C-terminal of the peptide stem) varies. In most 
cases, D-Ala residue, but this residue can be replaced by other residues such as Ser, Gly or D-





Table 1.  Amino acid variations in the peptide stem. *These residues result from reactions 
occurring after the formation of cytoplasmic precursors. †The process of formation of these residues is 
unclear. ‡ In this organism, a 10: 1 ratio of lysine to hydroxylysine was foun, adapted from (Vollmer 
et al., 2008). 
 
 
1.2.1.1.2.2. Variation in the lateral chain 
For a given bacterium, the composition of the lateral chain is invariable, but its composition 
and length (one to five residues) varies between bacteria. It can contain D- or L-amino acids, 
for example, two L-Ala in E. faecalis, D-Asp or D-Asn in E. faecium, or five Gly in S. 
aureus. After polymerisation of peptide stems, the lateral chains form cross bridges (Vollmer 





1.2.1.1.3. PG crosslinks 
Three modes of cross-linking exist (Fig. 9): 
1- 3-4 Cross-links, these types of crosslinks are the most common, they are made by 
D,D-transpeptidases. This type of cross-link results from the transpeptidation between 
the amino group of the side chain of the residue at the position 3 (acceptor peptide 
subunit) and the D-Ala at position 4 (donor peptide subunit). The linkage can be direct 
or not depending on the presence of a lateral chain  (van Heijenoort, 2001). 
2- 3-3 Cross-links; this type can be found in certain Corynebacteria and mycobacteria 
and is made by L, D-transpeptidases. This type of cross-link results from the 
transpeptidation between the amino group of the side chain of the residue at the 
position 3 and the diamino acid in the position 3 (Vollmer et al., 2008). 
3- 2-4 Cross-links, this kind of crosslink is rare and found in certain species of bacteria 
(Coryneform) particularly in phytopathogenic Corynebacteria. This type of cross-link 
involves the α-carboxy group of the D-Glu at the position 2 and the carboxy group of 
the D-Ala of the acyl donor at the position 4 (Schleifer and Kandler, 1972). The 
enzymes responsible for this type of crosslinks have not been described  
The degree of cross-linking (“crosslink index”) can vary from one species to another. For 
example, it is 20% for Escherichia coli and >90% for S. aureus (Vollmer et al., 2008). 
 
1.2.1.1.4. Classification of peptidoglycan composition 
The classification of PG structures ‘‘Chemotypes’’ can be achieved by a tridigital system 
(table 2)  (Schleifer and Kandler, 1972). 
1- The first letter (Roman capital letter) refers to the mode of cross-linking: A: 3-4 Cross-
Linking or B: 2-4 Cross-Linking. 
2- The second digit (Number) indicates the type of interpeptide bridge involved in cross-
linking. (For example direct cross-linked is 1) 
3- The third letter (Greek) depends on the amino acids found in position 3 of the peptide 
stem. 
    Several examples of peptidoglycan chemotypes are described in (Fig. 9). 






Table 2. Summary of the peptidoglycan classification scheme. The classification of PG structures 
‘‘chemotypes’’ involves a tri-digital system describing the type of crosslink, the presence of cross-


















                                 
                              
                            
Figure 9. Examples of peptidoglycan chemotypes of different bacteria. (A), A1γ chemotype 
(Escherichia coli). A: 3-4 Cross-links, 1: direct cross-links (No interpeptide bridge), γ: m-A2pm in 
position 3. (B), A2 chemotype (Micrococcus lysodeikticus), A: 3-4 cross-links, 2: crossbridge made of 
a polymerized peptide subunits with L- Lysine in position 3. (C) A3α chemotype (Enterococcus 
faecalis), A: 3-4 cross-links, 3: crossbridge made of monocarboxylic L-amino acid, α: L-Lysine at 
position 3. (D), A4α chemotype (Enterococcus faecium), A: 3-4 Cross-links, 4: crossbridge made of a 
dicarboxylic amino acid, α: L-Lysine in position 3. (E) B1α chemotype (Microbacterium lacticum), B: 
2-4 cross-links, 1: crossbridge made of L- diamino acids and glycine, α: L-Lysine in position 3. (F), 
B2β chemotype (Corynebacterium pointsettiae), B: 2-4 Cross-links, 2: crossbridge made of a D-
diamino acid, β: L-homoserine in position 3. 
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1.2.1.2. PG synthesis 
Peptidoglycan synthesis occurs in three stages summarised in (Fig. 10) (van Heijenoort, 
2001). The first cytoplasmic stage results in the formation of the soluble precursors (UDP-
MurNAc-pentapeptides) (Barreteau et al., 2008). The second stage is membrane-associated; 
soluble precursors are transferred on a lipid transporter at the inner face of the cytoplasmic 
membrane then GlcNAc and the lateral chains are added before translocation at the cell 
surface. During the last extracytoplasmic stage, PG precursors are incorporated into the 
existing network by the action of transpeptidases and glycosyltransferases (Scheffers and 
Pinho, 2005; van Heijenoort, 2001).  
 
 
Figure 10. Major steps of PG synthesis. Step 1 occurs in the cytoplasm and leads to the production 
of soluble precursors (UDP-MurNAc-pentapeptides) by action of several enzymes. Step 2 is a 
membrane-associated step which starts at the inner side of the cytoplasmic membrane. It is responsible 
for synthesis of lipid-linked precursors and their translocation on the outer face of the cytoplasmic 
membrane. Step 3 of PG synthesis is the polymerization of PG precursors by enzymes called D,D-
transpeptidases or Penicillin Binding Protein (PBP). 
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1.2.1.2.1. Cytoplasmic step (synthesis of soluble precursors) 
The cytoplasmic steps can be divided into three series of reactions described below. 
 
1.2.1.2.1.1. Biosynthesis of UDP-GlcNAc 
Fructose-6-Phosphate (F-6-P) is first converted to Glucosamine-6-Phosphate: (GlcN-6-P) by 
the action of the glucosamine-6-phosphate synthase (GlmS). GlcN-6-P is then converted to 
Glucosamine-1-Phosphate (GlcN-1-P) by the action of the phospho-glucosamine mutase 
GlmM. Finally, GlcN-1-P is transformed to UDP-GlcNAc by the action of the bifunctional: 
(GlmU) enzyme, which has both GlcN-1-P acetyl transferase and N-acetylglucosamine-1-
phosphate uridyl transferase activities. The overall reactions are summarised in Fig. 11A. 
 
1.2.1.2.1.2. Biosynthesis of UDP- MurNAc 
This step requires two enzymes: MurA transfers enolpyruvate from PEP to position 3 of the 
GlcNAc residue to yield UDP-GlcNAc enolpyruvate. The enolpyruvate moiety is then 
reduced to D-lactoyl by MurB to produce UDP-MurNAc. These two reactions are 
summarized in Fig. 11B. 
 
1.2.1.2.1.3. Biosynthesis of UDP-MurNAc-pentapeptide 
This step requires several enzymes that sequentially add amino acids onto the lactoyl group of 
UDP-MurNAc and form amide or peptide bonds. Each amino acid is added following 
activation with ATP. These enzymes are called Mur Ligases (MurC, MurD, MurE and MurF). 
MurC incorporates L-Ala; MurD incorporates D-Glutamic Acid; MurE incorporates the 
diamino acid (usually L-Lys or meso-DAP) and MurF incorporates the dipeptide D-Ala-D-
Ala. The reactions are described in Fig. 11C using E. coli peptidoglycan composition as an 
example. 
 
Figure 11. Cytoplasmic reactions leading to the synthesis of soluble precursors. (A), formation of 
the soluble precursor UDP-GlcNAc from F-6-P. Three enzymes (GlmS, GlmM and GlmU) are 
involved. (B), formation of UDP-MurNAc from UDP-GlcNAc by the combined activity of MurA and 
MurB. (C), formation of the soluble UDP-MurNAc-pentapeptide precursors. Sequential additions of 




1.2.1.2.2. Membrane associated step (synthesis of lipid-linked intermediates) 
1.2.1.2.2.1. Formation of lipid I 
The soluble precursor UDP-MurNAc-pentapeptide is transferred to a lipid transporter called 
bactoprenol. The bactoprenol is a hydrophobic transporter that helps to transfer the soluble 
(hydrophilic) PG precursors from the aqueous environment of the cytoplasm through the 
hydrophobic cytoplasmic membrane. This first step is catalysed by the enzyme MraY that 
adds the UDP-MurNAc onto bactoprenol. 
 
1.2.1.2.2.2. Formation of lipid II 
The enzyme MurG then adds a GlcNAc residue to lipid I to form lipid II. At this stage, the 
lateral chain is added to the disaccharide-pentapeptide by aminoacyl transferases. L-amino 
acids are added by enzymes using aminoacyl-tRNAs as substrates. In E. faecalis, the enzymes 
BppA1 and BppA2 add two L-Ala residues as a lateral chain. D-amino acids are added by 
enzymes carrying out ATP-dependent carboxylate-amine ligations (Bellais et al., 2006). 
 
1.2.1.2.2.3. Translocation of lipid II 
Lipid II is translocated across the cytoplasmic membrane to the extra-cytoplasmic space by a 
‘‘flippase’’. Using different experimental strategies, three enzymes have been proposed to 
play this role: FtsW (Mohammadi et al., 2011), MurJ & (Sham et al., 2014)  or AmJ (Meeske 
et al., 2015). 
 
1.2.1.2.3. Extra-cytoplasmic step (polymerization reactions) 
During this stage, the PG precursors attached to the lipid transporter are incorporated into the 
existing PG (Fig. 10). Polymerisation reactions are catalysed by bifunctional enzymes that are 
known as penicillin binding proteins (PBPs). PBPs can have two different enzymatic 
activities: they act as glycosyltransferases to extend the glycan chains and transpeptidases to 
form the peptide crosslinks. Bifunctional PBPs with both glycosyltransferase and 
transpeptidases activities are called ‘‘class A’’ PBPs. PBPs with only transpeptidase activity 
called ‘‘class B’’ PBPs. Finally low molecular weight PBPs with carboxypeptidase activity 
called ‘‘class C’’ PBPs. During the polymerisation reaction, one D-Ala-D-Ala extremity of a 
precursor used as a ‘‘donor’’ is cleaved to form a covalent bond with the PBP. The cleavage 
reaction provides energy necessary for the transpeptidation reaction which occurs outside the 
cytoplasmic membrane in the absence of energy donors such as ATP (van Heijenoort, 2007; 
van Heijenoort, 2001; Johnson et al., 2013). 
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1.2.2. Polymers covalently associated to PG 
Gram-positive bacteria produce various polymers that are covalently anchored to the PG 
molecule. The following section will describe the composition of major types of polymers 
found in E. faecalis and briefly describe some of their roles during growth and interaction 
with the host during pathogenesis. 
 
1.2.2.1. Teichoic acids 
In Gram-positive bacteria, teichoic acids (TAs) are envelope components that can represent 
more than 50% of the cell wall. TAs are covalently bound to the C6-OH group of MurNAc 
residues. TAs are attached to peptidoglycan via a linkage unit composed of two sugars 
(GlcNAc and ManNAc) and contain a variable number of phosphate repeats (Fig. 12) 
(Neuhaus and Baddiley, 2003). The phosphate groups of TAs are negatively charged and 
represent a polyanionic matrix. The negative charge conferred by TAs can be modulated via 
the esterification of TAs with D-alanyl esters and glycosyl residues (Neuhaus and Baddiley, 
2003). Most TA are glycerol-phosphate or ribitol-phosphate polymers as shown in Fig. 12A 
In rare cases, TAs can have an unusual composition. In E. faecium, The composition of TAs 
and their structure were analyzed by GC-MS and NMR. A mixture of glucose, glycerol, and 
phosphate was found in an approximate ratio of 2:1:2. The structure of the repeating unit of 
TAs was solved by NMR and shown to correspond to contain a kojibiosyl [α-D-
glucopyranosyl-(1.2)-D-glucose] (Fig. 12B). In E. faecalis, the composition of TAs remains 
unclear, but it was proposed that two TAs are produced in equal amounts with repeating units 
of 6)[α-L-Rhap-(13)]β-D-GalpNAc-(15)-Rbo-1-P and 6)β-D-Glcp-(13)[α-D-
Glcp-(14)]-β-D-GalpNAc- (15)-Rbo-1-P  (Fig. 12C). 
 
For a long time, it has been proposed that the presence of TAs was essential because repeated 
attempts to build null mutants affected in various steps of the biosynthetic pathway had 
remained unsuccessful. Work on S. aureus showed that it is possible to abolish the production 
of TAs by inactivating tagO, the gene involved in the first step of the TA synthesis (the 
formation of undecaprenylPP-GlcNAc, required to generate the linkage unit) (Weidenmaier et 
al., 2004). Based on this result, it was proposed that previous unsuccessful attempts to build 
other mutants could be explained by the toxic accumulation of incomplete TA products in the 




Figure 12. Schematic representation of TA from Gram-positive bacteria. (A), TA structure of S. 
aureus, P, phosphate; GlcNAc, N-acetylglucosamine; ManNAc, N-acetylmannosamine; Gro, glycerol; 
A, D-alanine and Rto, ribitol  (Weidenmaier and Peschel, 2008) (B), TA structure of E. faecalis 12030  
(Wang et al., 1999). (C), Structure of E. faecalis TA repeating units of E. faecalis V583 (Geiss-
Liebisch et al., 2012). 
 
 
Several roles have been proposed for teichoic acids. They are used as receptors for phages 
adsorption and can also modulate the resistance of bacteria to antimicrobial peptides (Fig. 
13). 
 
Figure 13. Roles of teichoic acid (TAs) in the cell wall of S. aureus. TAs are involved in 
localization of cell-division machinery, control of autolysin activity, modulation of biofilm formation 
the adsorption of phages, interactions with host cells, susceptibility and/or resistance to antimicrobial 





In addition to TAs, the cell wall of gram-positive bacteria can also contain capsules (CPSs) 
that form a “shield” around the bacterium (Chapot-Chartier and Kulakauskas, 2014). The vast 
majority of CPSs are made of carbohydrates covalently bound to PG. Only few capsules are 
made of polypeptides, the most studied example being the poly-γ-D-glutamic acid of Bacillus 
anthracis  (Candela and Fouet, 2005). 
Capsules made of carbohydrates are covalently anchored onto the C6-OH groups of MurNAc 
(Coley et al., 1978) or GlcNAc residues in the case of group B streptococci (Deng et al., 
2000). In the case of Bacillus anthracis, which contains a peptidic caspule made of poly-γ-D-
glutamic acid, it is anchored onto the peptide stems of PG (Candela and Fouet, 2005). 
 
The composition of CPSs is variable between strains of the same species. Different CPS 
compositions and structures underpin the capacity of pathogenic strains to interact with their 
host. One of the best studied example is the CPS of S. pneumoniae which is a major virulence 
factor (Garcia et al., 2000). 
 
E. faecalis produces a capsule composed of glucose, galactose residues and glycerol 
phosphate encoded by a genetic locus named cps containing 11 ORFs (Hancock and Gilmore, 
2002). The capsule has been shown to contribute to define four of the 21 serotypes proposed 
by Maekawa (Maekawa et al., 1992; Hancock et al., 2003).  The four capsule serotypes (A, B, 
C, or D) have been analysed (Thurlow et al., 2009). It was shown that seven of the nine genes 
in the cps operon are crucial for capsule production. Serotypes A and B do not make a 
capsular polysaccharide, and the fact that they define distinct serotypes indicate that this 
typing method also recognize other surface components. Biochemical analyses suggested that 
one cps gene (cpsF) is responsible for glucosylation of serotype C capsular polysaccharide 
(Thurlow et al., 2009). 
 
1.2.2.3. Secondary cell wall polymers: the Enterococcal polysaccharide antigen (Epa) 
Several Gram-positive pathogens produce, in addition or in place of caspules and teichoic 
acids another type of polymer called “secondary cell wall polymer” (SCWP). Unike capsules, 
which are commonly considered as the outermost structures, such polymers are buried in the 
cell wall. They can play an important role in during growth and pathogenesis. 
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For example, B. anthracis produces a pyruvylated polysaccharide essential for the non-
covalent anchoring of surface proteins containing a surface-layer homology (SLH) domain. 
(Mesnage et al., 2000). 
It has been reported that in some cases, SCWP represent a large proportion of the cell wall, up 
to 50% (Doran and Mattingly, 1982). An example of a widespread SCWP is the rhamnose-
containing surface polysaccharide found in group A and group B streptococci as well as 
enterococci and lactococci (Mistou et al., 2016). 
This type of polymer contains rhamnose as a major component and a variable combination 
and linkages of Glc, GlcNAc, Gal, GalNAc and phosphate (Fig. 14) that define several 
Lancefield groups.  
 
Group A carbohydrate Group B carbohydrate Group C carbohydrate Group G carbohydrate








Figure 14. Composition of rhamnose-containing SCWP in Gram-positive bacteria (adapted from 
(Mistou et al., 2016). 
 
The rhamnopolysaccharides biosynthesis pathway follows 5 successive steps similar to most 
if not all surface polymers (Fig. 15). The synthesis starts by the addition of a UDP-GlcNAc 
residue on a lipid transporter (initiation); glycosyltransferases add monosaccharides to 
polymerise the glycan chain (elongation). At this stage, the polysaccharide chain is transferred 
at the cell surface via a membrane transporter (translocation) where it will be covalently 
linked to the MurNAc residue of PG (linkage). The last step corresponds to additional 
modifications that are currently not formally identified, but are likely to be mediated at least 







The role of the rhamnopolysaccharide has been studied in various Gram-positive organisms 
and it has been shown that it plays a major role in various steps of the infectious proccess. 
Mutants lacking the rhamnopolysacccharide have severe growth and cell division 
abnormalities (Caliot et al., 2012) suggesting that this polymer is important for the positioning 
or regulation of the activity of enzyme proteins involved in cell wall metabolism. 
Interestingly, modifications of the rhamnopolysaccharide that do not lead to growth defect are 
associated with a significant attenuation in virulence in a mouse peritonitis model (Xu et al., 
2000; Teng et al., 2009). 
 
Figure 15. Major steps of the rhamnopolysaccharide biosynthesis pathway. (Adapted from  
(Mistou et al., 2016). 
 
E. faecalis epa mutants also show an increased phagocyte uptake both in vitro  (Teng et al., 





1.2.3. PG Associated Proteins 
Bacterial surface proteins contribute in the host-pathogen and host-symbiont interactions. In 
Gram-positive bacteria, surface proteins can be covalently or non-covalently bound to PG. 
 
1.2.3.1. Covalent binding 
1.2.3.1.1. LPXTG 
The covalent binding of proteins is extremely conserved in Gram-positive bacteria and was 
first studied using protein A as a model protein (Schneewind et al., 1992). Proteins covalently 
bound to the PG are secreted proteins containing a signal peptide and a C-terminal sorting 
signal that consists of an LPXTG-like motif, a hydrophobic domain, and a positively charged 
tail  (Schneewind et al., 1992; Ton-That et al., 2004). After secretion, the protein is retained in 
the cytoplasmic membrane; the LPXTG-like consensus sequence is then recognized and 
cleaved by a transpeptidase called sortase which links it to the PG cross-bridge of precursor. 
This mechanism is summarized in (Fig. 16). Most genomes encode several sortases that 
recognise LPXTG-like sequences and anchor proteins on the PG by the same mechanism. 
E. faecalis and E. faecium produce LPxTG surface proteins considered to be important 
virulence determinants (Hendrickx et al., 2009). In E. faecalis, LPXTG proteins include the 
collagen-binding protein Ace and the pilin required for the assembly of type 4 pili (Hendrickx 






Figure 16. The SrtA-mediated sorting pathway in Gram-positive bacteria. Following 
transcription and translation, polypeptide precursors with an N-terminal signal peptide (SP, in 
blue) and a C-terminal sorting signal (in green: LPXTG motif, hydrophobic domain and 
positively charged tail (boxed +)) are secreted across the membrane through the Sec pathway. 
Following cleavage of the signal peptide, the exported protein is transiently retained in the 
membrane and then processed by the membrane-bound transpeptidase sortase SrtA, which 
recognizes the LPXTG sequence and cleaves its substrate between the threonine and glycine 
residues of the motif. An acyl-enzyme intermediate is formed between the active site cysteine 
of SrtA and the carboxyl-group of threonine. The enzyme then recognizes lipid II as the 
second substrate. Subsequent formation of a peptide bond between the carbonyl of the 
threonine and the free amino group of the cross-bridge peptide (CB) results in covalent 
attachment of the protein to lipid II. The surface protein is next incorporated into the mature 
PG via the cell wall synthesis machinery. It then follows expansion and reshaping of the PG 
during cell growth and division, upon the action of hydrolytic enzymes (autolysins) (Bierne 
and Dramsi, 2012). 
 
 
1.2.3.2. Non-covalent binding 
1.2.3.2.1. LysM  
LysM (Lysin Motif) is a ubiquitous domain that binds to PG in a non-covalent manner (Buist 
et al., 2008). LysM motifs are found in surface proteins from both Gram-negative and Gram-
positive proteins. They consist of imperfect repeats of 44 to 50 amino acid residues separated 
by linkers of low sequence complexity (Buist et al., 2008). LysM binding modules form a 
very conserved structure consisting of two beta strands flanked by two alpha helices 
(Bateman and Bycroft, 2000). 
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LysM domains are found at the N- or C-terminal of proteins and are often present in multiple 
copies to form multimodular domain (between 1 and 12 repeats). It has been proposed that 
LysM repeats are like “beads on a string” that confer additive binding (Mesnage et al., 2014). 
Recent work revealed that the structural organisation of LysM domains is very diverse and 
our beads on a string model is not universal. For example some eukaryotic LysM domains 
form trimeric structures via disulphide bounds (Ohnuma et al., 2008). In other cases, the 
binding can be mediated by more than one LysM module (Sánchez-Vallet et al., 2013) or at 
the interface between LysM and another domains (Schanda et al., 2014). LysM domains bind 
to GlcNAc-X-GlcNAc motifs in the glycan chains of PG. The acetyl groups of the GlcNAc 
residues are recognized by two hydrophobic pockets whilst several residues make stacking 
and hydrophobic interactions with the sugar backbone that fits in a well defined cleft (Fig. 
17). 
 
Figure 17. Structural model of a complex of an E. faecalis LysM module bound to a PG 
fragment. (A), key interactions between MurNAc-(GlcNAc-MurNAc) 2 and LysM residues are 
described. Hydrogen bonds are shown by dashed lines. The horizontal bars indicate that the 
hydrophobic interaction is to the face of a sugar ring. The two pockets interacting with N-acetyl 
groups are indicated by green lines. Also shown in blue is the binding location involving N15 which 
may be important for distinguishing between chitin and peptidoglycan (B) and (C), Model of a LysM 
module in complex with a peptidoglycan fragment. The peptide stem is shown in two possible 
orientations, either side of the glycan backbone, interacting either with G11/K16 or with L38 
(Mesnage et al., 2014). 
 
 
The subcellular localization of some LysM proteins has been studied (e.g., AcmA in L. lactis, 
LytN in S. aureus or Cse in Streptococcus thermophilus). These proteins were found to be 
localized at the septum, but it remains unknown if all LysM proteins are targeted to this 
region of the cell. This septal localization was proposed to be due to the presence of 
secondary cell wall polymers preventing the binding of LysM proteins on the cell surface 
(Steen et al., 2003). 
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Interestingly, LysM binding modules can have distinct charges (basic or acidic). In L. lactis, it 
has been shown that the basic LysM domain of AcmA can bind peptidoglycan at pH 4–10, 
whereas the LysM domain of AcmD only bound at a ~pH 4 (Steen et al., 2003). 
E. faecalis V583 encodes 12 proteins with LysM modules at their C-terminal. The 
glucosaminidase AtlA contains six C-terminal LysM modules (Eckert et al., 2006). 
 
1.2.3.2.2. Pbp and Ser/Thr kinase attached (PASTA) domains 
PASTA domains are made of imperfect repeats of approximately 70 residues found in 
proteins from Gram-positive bacteria. The crystal structure of S. pneumoniae Pbp2x in 
complex with cefuroxime, revealed that PASTA repeats could bind β-lactams (Gordon et al., 
2000). A couple of years later, it was proposed that PASTA domains could bind PG (Yeats et 
al., 2002). 
PASTA domains contain 2 (S. pneumoniae Pbp2x) to 5 repeats (Enterococcus faecalis PknB) 
of conserved structure. Apart from Pbp2x, where the two PASTA modules interact through a 
hydrophobic surface, other PASTA domains studied by X-ray crystallography present an 
extended conformation and form a linear structure  (Ruggiero et al., 2011a; Paracuellos et al., 
2010; Barthe et al., 2010) (Fig. 18). 
 
In silico experiments have proposed binding sites for PG fragments (Paracuellos et al., 2010), 
and it was suggested that binding to PG fragments could induce dimerization of PASTA-
containing proteins (Barthe et al., 2010; Paracuellos et al., 2010). 
Surprisingly, only two studies have shown a direct binding of PASTA motifs to PG fragments 
using surface plasmon resonance (Mir et al., 2011) or NMR (Squeglia et al., 2011). Muramyl 
tetrapeptides represent the minimal PG motif recognised by Mycobacterium tuberculosis 
PknB PASTA domains. Using several synthetic PG fragments, Mir et al. showed that mDAP, 
the presence of amidated Glu in position 2 and the MurNAc residue are important 
determinants for binding (Mir et al., 2011). In another study, B. subtilis PrkC was shown to 




Figure 18. Crystal structure of the PASTA domain from S. aureus serine/threonine kinase 
PrkC. Helices and β-strands are shown in orange and blue respectively (Ruggiero et al., 2011b). 
 
1.2.3.2.3. SH3b 
The SH3b domain was first described in the lysostaphin enzyme (Baba and Schneewind, 
1996). Lysostaphin is produced by Staphylococcus simulans biovar staphylolyticus and 
specifically digests S. aureus PG (Thumm and Gotz, 1997). The PG binding activity of the 
SH3b domain has been studied in a lysostaphin close homolog, S. capitis ALE-1, also 
targeting S. aureus. The structure of this domain is very similar to the SH3 (Src Homology 3) 
domains from eukaryotes that recognises short proline-rich peptide segments in proteins 
(Pawson, 1995). The SH3b domain of ALE-1 (92 amino acids) is sufficient to bind 
peptidoglycan in vitro (Lu et al., 2006). 
 
ELISA assays revealed that ALE-1 SH3b domain specifically binds S. aureus PG. The 
presence of 5 glycine residues in the PG is required for binding. It has therefore been 
suggested that SH3b specifically recognises the pentaglycine motif in the PG. It was proposed 
that the pentaglycine stem could bind a deep and narrow groove in the N-terminal region of 




SH3b domains are conserved in bacteria. Interestingly, some bacteria producing proteins with 
SH3b domains have PG crossbridges (e.g. L-Ala-L-Ala in E. faecalis and S. agalactiae), but 
some others have a direct crosslink (eg., Anabaena variabilis). How different SH3b domains 
recognise different PG structures is unknown. 
 
Figure 19. Crystal structure of the ALE-1 SH3b cell wall-targeting domain. ALE-1 SH3b domain 
specifically binds S. aureus PG. The presence of 5 glycine residues in the PG is required for binding. 
SH3b specifically recognises the pentaglycine motif in the PG. A deep and narrow groove in the N-
terminal region of the domain has been proposed to bind the pentaglycine stem (Lu et al., 2006). 
 
1.2.3.2.4. WxL 
This domain was recently identified based on sequence analysis of secreted proteins in E. 
faecalis (Brinster et al., 2007a). Sequence comparisons revealed the presence of two WxL 
motifs separated by 80 to 120 residues. This consensus is found in 27 E. faecalis proteins 
mostly grouped in 8 clusters on the chromosome (Brinster et al., 2007a). 
WxL domains are sufficient for PG binding but the motif they recognise in PG has not been 
identified yet. WxL proteins are only present in low GC Gram-positive bacteria including 
some pathogens (Listeria monocytogenes, E. faecium and Bacillus cereus) and for these 
species, the number of WxL proteins can vary between strains.  
Some WxL proteins have been reported to contribute to virulence. One example is the E. 
faecalis internaline ElrA that contributes to stimulate the host inflammatory response 
(Brinster et al., 2007b). More recently, it was proposed that in E. faecium, WxL proteins 
interact to form surface complexes involved in interactions with the host extracellular matrix 
proteins (Galloway-Pena et al., 2015). 
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1.3. Peptidoglycan hydrolases (PGHs) 
 
1.3.1. Definition 
Peptidoglycan can be cleaved by enzymes called peptidoglycan hydrolases (PGHs). Some 
PGHs can cause cell lysis and in this case they are called autolysins. This chapter will 
describe the enzymatic activities of PGHs, their physiological function and give examples of 
PGHs well studied in Gram-positive bacteria that have been used as model systems. 
 
1.3.2. Classification 
Several types of PGHs have been described based on the PG bond they cleave: (i) glycosyl 
hydrolases: (N-acetylglucosaminidases and N-acetylmuramidases), (ii) N-acetylmuramoyl-L-
Alanine amidases, and (iii) peptidases (Fig. 20). 
 
 
Figure 20. Schematic representation of PGHs cleavage sites (E. faecalis PG is given as an 
example). Glycosyl hydrolases including N-acetylglucosaminidases and N-acetylmuramidases cleave 
the glycan chains. N-acetylmuramoyl-L-Alanine amidases cleave between the MurNAc residues and 




1.3.2.1. Glycosyl hydrolases 
Three classes of glycosyl hydrolases are able to cleave PG glycan strands: N-
acetylglucosaminidases, N-acetylmuramidases (also called lysozymes), and lytic 
transglycosylases. The latter two cleaving the same glycosidic bond (Fig. 21) (Vollmer et al., 
2008). 
N-acetylglucosaminidases hydrolyse the glycosidic bond between GlcNAc residues and 
adjacent MurNAc and generate a reducing GlcNAc end (Fig. 21, cleavage 1). 
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A large number of PGHs with glucosaminidase activity belong to the CAZy family GH73. 
This catalytic domain is often associated with one or several cell wall-binding domains (e.g. 
the LysM domain). 
N-acetylmuramidases (also called lysozymes) hydrolyse the glycosidic bond between 
MurNAc and GlcNAc residues and generate a reducing MurNAc end (Fig. 21, cleavage 2). 
Lytic transglycosylases have the same cleavage site as muramidases but are formally not 
glycosylhydrolases as they do not use a water molecule. Instead of a reduced MurNAc 
extremity, they generate anhydroMurNAc residues (Fig. 21, cleavage 3). This activity is rare 
in Gram-positive bacteria. The digestion product of lytic transglycosylases has been reported 









Figure 21. Cleavage of PG bonds by glycosyl hydrolases. The bonds cleaved by N-
acetylglucosaminidases, N-acetylmuramidases and lytic transglycosylases and the corresponding 
products are described. 
 
 
1.3.2.2. N-acetylmuramyl-L-alanine amidases 
N-acetylmuramyl-L-alanine amidases cleave the amide bond between MurNAc and the N-
terminal L-alanine residue of the stem peptide (Fig. 22, Ami). These enzymes, also known as 
amidases, are present in bacterial and bacteriophage/prophage genomes (Young, 1992; Lopez 
et al., 1981). 
1.3.2.3. Peptidases 
Several classes of PGHs can cleave the bonds between amino acids in the stem peptides 




Endopeptidases cleave the bonds within the peptide stems or the crosslinks generated by 
PBPs and can therefore cause cell lysis (Shockman and Höltje, 1994). They can recognise 
several types of bonds. L,D endopeptidases cut between the first L-Ala and the γ-D-Gln 
residue. D,L endopeptidases cut between the γ-D-Gln residue and the diamino acid or at the 
end of the lateral chain in crosslinked peptide stems. A summary of the different types of 
peptidases is presented in Fig. 22. 
Carboxypeptidases cleave the extremity of peptide stems and can therefore not trigger cell 
lysis. They can be D,D-carboxypeptidases (cleaving between D-Ala in position 4 and D-Ala 
in position 5) or L,D-carboxypeptidases (cleaving between the L-diamino acid in position 3 




Figure 22. Cleavage of PG bonds by peptidases. N-acetylmuramoyl-L-alanine amidases (Ami) 
hydrolyse the amide bonds between the lactyl group of MurNAc and the L-alanine of the stem peptide. 
Some amidases (anhAmi) specifically cleave at 1,6-anhydroMurNAc residues, which are the 
hallmarks of PG turnover products in many species. Endopeptidases (DD-EPase, LD-EPase, DL-
EPase) cleave amide bonds in the peptides. The cleavage sites for LD- or DL-endopeptidases are 
indicated in a dimeric (cross-linked) peptide, but there are also cleavage sites for these enzymes in 
monomeric peptides. Carboxypeptidases (DD-CPase, LD-CPase, DL-CPase) hydrolyse peptide bonds 







1.3.3. The physiological role of the PGHs 
The enzymatic activity of PGHs contributes to several functions during growth and also 
modulates some properties of bacterial cell populations. 
 
1.3.3.1. Contribution to peptidoglycan biosynthesis 
During cell growth, the PG molecule undergoes partial hydrolysis. Breaking PG bonds is 
required to allow the incorporation of new precursors in the existing network. This process 
involves lytic transglycosylases in E. coli and some endopeptidases such as LytE in B. subtilis  
(Carballido-Lopez et al., 2006). 
It is widely accepted that some PGHs are part of the PG synthetic machinery complexes 
involving PBPs and cytoskeleton elements such as MreB and FtsZ (den Blaauwen et al., 
2008). During growth, the activity of carboxypeptidases depends on the availability of 
precursor with pentapeptide stems used by the PBPs to polymerise PG. These enzymes 
regulate the degree of crosslinking in the PG sacculus and also contribute to the subcellular 
localisation of other proteins involved in cell division (Morlot et al., 2004). 
 
1.3.3.2. Role during sporulation and germination 
After asymmetric division (the first step required for sporulation), the asymmetric septum is 
digested by PGHs such as SpoIID (Gutierrez et al., 2010). This allows the engulfment process 
to take place. Later during sporulation, the spore peptidoglycan undergoes maturation, a 
process which leads to the formation of δ-lactam MurNAc residues. This step requires the 
activity of amidase CwlD which cleaves the peptide stem, and the MurNAc deacetylase PdaA 
which forms the lactam ring (Vollmer et al., 2008). 
In B. subtilis, the L-alanyl-D-glutamate endopeptidase LytH removes the remaining peptide 
stems, a modification required for increased heat resistance (Horsburgh et al., 2003). Once the 
spore is formed, the mother cell is lysed by PGHs which act in synergy (LytC, CwlC and 
CwlH). Finally, germination of spores also requires the combined activity of several PGHs 









1.3.3.3. Septum cleavage during cell division 
Towards the end of the cell division process, the septum has to be hydrolysed to release two 
daughter cells. This requires the activity of PGHs. In some cases, several enzymes have been 
reported to be important for this process (Sle1 and Atl in S. aureus; (Yamada et al., 1996; 
Kajimura et al., 2005). In several Gram-positive bacteria, one particular PGH is dedicated to 
septum cleavage and plays a major role. This is the case of AtlA in E. faecalis (Mesnage et 
al., 2008), Cse in S. thermophilus (Layec et al., 2009)  LytB in S. pneumoniae (de las Rivas, 
2002) or AcmA in L. lactis (Buist et al., 1995). 
 
1.3.3.4. Resuscitation of dormant cells 
Some bacteria can enter a viable but non-culturable state. This corresponds to a physiological 
state where the cells don not divide and display a very low metabolic activity, usually 
following prolonged stationary phase. This is well established for Micrococcus luteus and 
Mycobacterium tuberculosis which can be found as “dormant” cells. Some PGHs called 
resuscitation-promoting factors (Rpf) can induce the growth of dormant cells (Mukamolova et 
al., 1998). In Mycobacterium tuberculosis, five Rpf proteins have been described  (Keep et 
al., 2006). 
 
1.3.3.5. Contribution to natural competence 
Some bacteria are naturally competent, which means they can be transformed by exogenous 
DNA. This is the case of S. pneumoniae and B. subtilis. In S. pneumoniae, cell lysis by PGHs 
is an important step that promotes integration of new genes in the chromosome. It has been 
shown that within a population, competent cells are producing both an immunity factor and a 
bacteriocin that can activate autolysins (Guiral et al., 2005). As a result, competent cells are 
able to trigger the lysis of non-competent cells, a phenomenon known as allolysis.  
 
1.3.3.6. PGHs as toxins to lyse competitors 
PGHs can be involved in the cell lysis of competitors. One of the most studied examples is 
lysostaphin (Thumm and Gotz, 1997). This enzyme is produced by S. simulans biovar 
staphylolyticus. It cleaves the pentaglycine crossbridge specifically found in S. aureus PG. 
The lysostaphin gene is encoded by a plasmid, which also contains genes encoding immunity 
factors. These immunity factors modify the PG crossbridges in S. simulans by incorporating 




1.3.4. E. faecalis PGHs 
The E. faecalis genome encodes 21 putative peptidoglycan hydrolases (PGHs), including 3 
amidases, 5 endopeptidases, 6 glucosaminidases, and 7 proteins related to muramidases (Fig. 
23). 
 
Figure 23. Putative PGHs encoded by E. faecalis V583. E. faecalis V583 genome encodes 21 
putative peptidoglycan hydrolases (PGHs), including 3 amidases (blue boxes), 5 endopeptidases 
(green boxes), 6 glucosaminidases (yellow boxes), and 7 proteins related to muramidases (pink boxes). 
   
 
Analysis of a limited set of strains suggested that only a 7 these genes are ubiquitous EF0114, 
EF0252, EF0799 (AtlA), EF1293, EF1518, EF1583, EF2367. 
Analysis of PGH activities in cell extracts and supernatants by zymography indicates that 
only a limited number of the enzymes encoded by E. faecalis can be detected  (Mesnage et al., 
2008). In the strain JH2-2, three activities have been reported: AtlA, AtlB and AtlC. Another 
enzyme encoded by a prophage (EF1473, EnpA) has been expressed as a recombinant protein 
in E. coli and its PGH activity has been studied (Reste de Roca et al., 2010). 
 
1.3.4.1. AtlA 
AtlA is a 737 amino acid-long modular protein (Fig. 24A) composed of: 
- A signal peptide (residues 1-53); although AtlA signal peptide is unusually long, it has 
all the expected properties (a charged N-terminal sequence followed by a hydrophobic 




- An N-terminal domain (residues 54-171) rich in Serine/Threonine/Glutamic acid and 
Proline (11%, 27%, 14% and 12%, respectively). Unpublished results in the laboratory 
have shown that this domain is glycosylated and that this modification inhibits the 
activity of the enzyme (Bartek Salamaga, unpublished). This domain is cleaved by 
proteases in E. faecalis, and this cleavage (which also removes AtlA glycosylation) 
increases the activity of the enzyme. 
- A catalytic domain (residues 172-334) that displays an N-acetylglucosaminidase 
activity (Eckert et al., 2006). This domain belongs to the CAZy family GH73 that 
contains a very large number of bacterial glucosaminidases (Lipski et al., 2015).  
- A C-terminal LysM domain made of 6 imperfect repeats (Fig. 24B) responsible for the 
peptidoglycan binding activity of the enzyme. The presence of this domain is crucial 
for the activity of the enzyme, and its truncation reduces the activity AtlA by 
approximately 500-fold (Eckert et al., 2006). 
53 171 335 737













Figure 24. Modular organization of E. faecalis AtlA. (A), Domain organization of E. faecalis AtlA. 
Amino acid numbers refer to the transition between domains. SP, signal peptide; STEP-rich, catalytic 
and LysM domain. (B), Sequence alignment of the six AtlA LysM repeats. Numbering refers to 
residues corresponding to the beginning of each LysM fold, linker sequences are in italics. Identical 
amino acids in at least four modules are in dark grey boxes, conserved amino acids are in light grey 
boxes. (C), Chain-forming phenotype of the E. faecalis atlA mutant. 
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AtlA was originally identified during the screening of an expression library built in E. coli 
(Xu et al., 1997). In this work, a screen was carried out to identify recombinant E. coli 
colonies producing E. faecalis antigens recognized by human antisera from patients suffering 
from endocarditis caused by E. faecalis. Following this study, AtlA enzymatic activity was 
shown using zymogram assays (Qin et al., 1998). It was also reported that AtlA was able to 
cause cell lysis when the cells were re-suspended in phosphate buffer, as opposed to the atlA 
mutant which did not lyse at all. These results represent the first characterization of AtlA 
showing that it is the major autolysin in E. faecalis (Qin et al., 1998). AtlA is active against E. 
faecalis cells (Emirian et al., 2009) but has a relatively low activity as compared to AtlB (see 
below). 
AtlA is required for the separation of daughter cells after cell division. This was confirmed as 
a result of the long chains that formed by ΔatlA mutant (Fig. 24C). 
It has been reported that AtlA is essential for biofilm development (Kristich et al., 2008). This 
role is due to the autolytic activity of AtlA which is critical for the release of extracellular 
DNA (eDNA), a key component for the biofilm formation. 
 
1.3.4.2. AtlB 
In strain JH2-2, AtlB can be detected as a 45 kDa band with autolytic activity on a zymogram 
containing E. faecalis cells as a substrate (Mesnage et al., 2008). It was purified from culture 
supernatants using ammonium sulfate precipitation and ion exchange chromatography. The 
gene encoding AtlB (EF0355) was identified based on mass spectrometry analyses of tryptic 
digests of the protein. Deletion of the candidate gene and complementation of the mutant 
confirmed that AtlB is encoded by EF0355. The N-acetylmuramidase activity of AtlB was 
identified using mass spectrometry analysis of muropeptides solubilized by the recombinant 
enzyme produced in E. coli. AtlB is a 433 amino acid-long modular protein (Fig. 25) encoded 
by a prophage that is not present in all E. faecalis strains. This PGH is composed of: 
- A canonical signal peptide (residues 1-22). 
- An N-terminal catalytic domain (residues 23-226) that belongs to the CAZy family 
GH25; the model enzyme corresponding to this family of muramidases is the 
mutanolysin produced by Streptomyces coelicolor  (Rau et al., 2001). 
- Two C-terminal LysM repeats separated by a very short sequence and with a lower pI 

















Figure 25. Modular organization of E. faecalis AtlB. (A), Domain structure of E. faecalis AtlB. 
Amino acid numbers refer to the transition between domains. SP, signal peptide. (B), Sequence 
alignment of the two AtlB LysM repeats. Numbering refers to residues corresponding to the beginning 
of the LysM fold. Conserved amino acids are in light grey boxes. 
 
The physiological role of AtlB is poorly understood. In the absence of AtlA, AtlB contributes 
to septum cleavage converting long cell chains into diplococci but is not very active  
(Mesnage et al., 2008). This was confirmed in vitro using recombinant AtlB enzyme to cleave 
the septum of long cell chains of a DatlA mutant. Incorporation of 14C-GlcNAc in PG during 
growth indicated that AtlB is not required for the insertion of novel PG precursors during 
growth. AtlB was found to be associated with the release of a small proportion of PG 
fragments into the growth media during stationary phase (Mesnage et al., 2008). 
 
1.3.4.3. AtlC 
In strain JH2-2, AtlC can be detected as a 42 kDa band with autolytic activity on a zymogram 
containing E. faecalis cells as a substrate (Mesnage et al., 2008). The gene encoding AtlC was 
identified using BLAST searches in order to find PGHs similar to AtlB. The gene encoding 
AtlC was deleted and complemented to confirm that it encodes the 42k Da band with PG 
hydrolytic activity detected in E. faecalis crude extracts. AtlC shares 69 % identity with AtlB 
(Fig. 26) and its physiological role is unknown. 
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AtlB  SSIAAKLGTTYQALAALNGLANPNLIYPGQTLNY  
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Figure 26. Amino acid sequence alignments of V583 EF0355 (AtlB) and EF1992 (AtlC). AtlC 




EnpA (EF1473) was identified based on the genome sequence analysis. It is a large protein of 
1721 residues encoded by a prophage that is only present in some E. faecalis strains. The only 
EnpA domain recognized by the pfam database corresponds to a short C-terminal sequence of 
approximately 90 residues similar to endopeptidases belonging to the M23 family of 
peptidases (Fig. 27). These enzymes include lysostaphin (see paragraph 1.3.3.6). EnpA is 
poorly active against whole sacculi but displays a high activity against soluble disaccharide-
peptides (Reste de Roca et al., 2010). Enzymatic assays using purified peptidoglycan 
fragments showed that EnpA cleaves the amide bond generated by PBPs, i.e. between the end 
of the PG crosslink and the D-Ala4 of the donor stem. Unlike lysostaphin that only cleaves S. 
aureus PG, EnpA can cleave disaccharide-peptides from a wide range of bacteria, but is not 
active against directly crosslinked muropeptides (Reste de Roca et al., 2010). The inactivation 
of the enpA gene, alone or in combination with the inactivation of atlA, atlB and atlC has no 
phenotype, suggesting that this enzyme may be specifically produced during the excision of 




LytM    206 GGGAHYGVDYAMPENSPVYSLTDGTVVQAGWSNYGGGNQVTIKEANSNNYQWYMHNNRLT--VSAGDKVKAGDQIAYSGSTGNSTA-------PHVHFQRMSG  299 
Lyso    262 NGGIHYGVDFFMNIGTPVKAISSGKIVEAGWSNYGGGNQIGLIENDGVHRQWYMHLSKYN--VKVGDYVKAGQIIGWSGSTGYSTA-------PHLHFQRMVN  355 
Ale-1   146 NGGNHYGVDFFMNVGTPVRAISDGKIVEAGWTNYGGGNEIGLVENDGVHRQWYMHLSKFN--VKVGDRVKAGQIIGWSGSTGYSTA-------PHLHFQRMTN  239 
LytH    223 GRRIHEGTDIFAHYGLPVKSTCYGVVEMKGWNRFG-GWRIGIRDINN-TYHYFAHLNGFAKGIKTGQIVEPGQVIGSVGSSGYGPPGTAGKFPPHLHYGMYKD  323 
EnvC    316 GELRWKGMVIGASEGTEVKAIADGRVILADW-LQGYGLVVVVEHGKG-DMSLYGYNQSAL--VSVGSQVRAGQPIALVGSSGGQGR-------PSLYFEIRRQ  408 
Zoo_A    41 GYPGHVGVDYAVPVGTPVRAVANGTVKFAGNGANHPWMLWMAGNCVLIQHADGMHTGYAH---LSKISVSTDSTVKQ-GQIIGYTGATGQVTGPHLHFEMLPA  139 
MilB     42 NGGNHYGVDFFMNVGTPVRAISDGKIVEAGWTNYGGGNEIGLVENDGVHRQWYMHLSNSMLKLVTELKLDKLLVGLVVQDILQHRIYIFKERPIPLGINGGMH  148 
 
EF1473 1395 YGDFHTGIDYAAPTGTPIPAQYPGLVDWVQSSSIGLGEHVGIKVADN-LWAMYGHMSRIRAKM--GDKVKAGQIVGDVGSSGWSTG-------PHVHYELRKG 1488 
      
 
Figure 27. Schematic representation of E. faecalis EnpA (A), Domain structure of E. faecalis 
EnpA. Amino acid numbers refer to the identified M23 peptidase domain shown in red. (B), Sequence 




1.4. Aims and objectives 
AtlA is a peptidoglycan hydrolase which can cause autolysis when the cells are resuspended 
in phosphate buffer (Qin et al., 1998). The potentially lethal activity of AtlA therefore has to 
be tightly controlled during cell growth and division. How this is achieved is unknown. 
Recent work in the laboratory has shown that the formation of long chains in the atlA mutant 
is associated with a lack of virulence in the zebrafish model of infection (Fig. 28). When 
zebrafish embryos (20h post fertilization) are infected with ca. 1000 CFUs of E. faecalis 
OG1RF (WT) strain, approximately 60% of the larvae die within 96h (red curve in Fig. 28). 
The injection of a similar number of cells forming long chains only causes 20% mortality 
(blue curve in Fig. 28), indicating that septum cleavage defect is associated with a loss of 
virulence. Sonication of the long chains, which separated cells without impairing viability, 





Figure 28. Virulence of E. faecalis forming long chains in the zebrafish model of infection. 
Survival of zebrafish larvae (n>20) following infection with E. faecalis OG1RF (WT) and atlA 
isogenic deletion mutant before (DatlA) and after (DatlA*) sonication to disperse long chains. 
 
Altogether, these results indicate that AtlA is a potential therapeutic target to control 
enterococcal infections, either by deregulating or abolishing its activity.  
 
The aim of this work was to identify the mechanisms responsible for the control of AtlA 
activity. We used two distinct phenotypes associated with AtlA activity: (i) the formation of 
diplococci/short chains and (ii) the cell surface enzymatic activity of this enzyme that can be 
detected on agar plates containing autoclaved cells as a substrate. 
Three objectives were identified: 
1. Isolate and characterise spontaneous mutants with impaired septum cleavage. 
2. Construct and screen a random transposon mutant library based on the Mariner transposon 




Materials and Methods 
2.1. Chemicals and enzymes 
All chemicals used in this project were purchased from Sigma or Fisher Scientific. Restriction 




All antibiotics used and their concentrations are listed in Table 3. Antibiotic stock solutions 
were prepared by dissolving the antibiotics in the corresponding solvent, filter-sterilised and 
stored at -20°C. 
 
 
Table 3. Antibiotic stock solutions and concentrations used in this project. 
a    concentration for E. coli   
b    concentration for E. faecalis 
 
2.3. Media 
All media were prepared using distilled water (dH2O). Sterilisation was performed by 
autoclaving for 20 min at 121°C. Heat-sensitive compounds were sterilised by filtration 
through 0.45µm filters (Sartorius) and added to the autoclaved media cooled down to 55°C. 
 
2.3.1. Brain heart infusion (BHI) 
BHI broth was prepared according to manufacturer’s instructions (37g/L) and eventually 














Ampicillin (Amp) 100 100 dH2O 
Chloramphenicol (Cm) 30 10 90% (v/v) ethanol 
Erythromycin (Ery) 30 200a/30b 90% (v/v) ethanol 
Gentamycin 128 128 dH2O 
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2.3.2. Super optimal broth with catabolite repression (SOC) 
SOC buffer was prepared according to (Sambrook and Maniatis, 1989). The composition is as 
follows: 
Tryptone (Oxoid) 2% (w/v) 
Yeast extract (Oxoid) 0.5% (w/v) 
NaCl  10 mM 
KCl  2.5 mM 
Once autoclaved, filter-sterilized MgCl2, MgSO4 and glucose were added at a final 
concentration of 10 mM, 10mM and 20mM, respectively.. 
 
2.3.3. Semi-solid medium for the isolation of spontaneous mutants 
THY broth (Todd Hewitt 37g/L containing 5% [m/v] yeast extract) was prepared and 
supplemented with a low concentration of agar 0.06% (m/v). The medium was poured into 
flasks and left at 4°C for 1h to set before inoculation with dilutions of pre-cultures suitable to 
see individual colonies. The cells were grown at 37°C without agitation and the appearance of 
spontaneous mutants with altered colony morphology followed over a period of 96h 
 
2.3.4. Agar plates to detect AtlA activity 
BHI-agar was autoclaved in the presence of freeze-dried M. luteus plates at a final optical 
density at 600 nm of 1.5.  
 
2.3.5. M17-Glu 
M17 broth was prepared according to manufacturer’s instructions (37g/L), autoclaved and 
supplemented with filter-sterilised glucose at a final concentration of 0.5% (m/v). 
 
2.3.6. SGM17 
M17-Glu broth was supplemented with 0.5 M sucrose and 2% (m/v) glycine and the pH ws 
adjusted at 7.0. 
 
2.4. Bacterial strains, plasmids and oligonucleotides 






Strains, plasmids  Relevant properties or genotypea Source  
and oligonucleotides 
Strains 
Enterococcus faecalis  
OG1RF Plasmid-free, virulent laboratory strain isolated from the oral cavity (Dunny et al., 1978)            
JH2-2 Plasmid-free laboratory strain (Jacob and Hobbs, 1974) 
V583 Clinical isolate, first E. faecalis sequenced (Paulsen et al., 2003) 
M. lysodeikticus  
ATCC4698  Reference strain for PG hydrolase activity assays ATCC 
Escherichia coli  
NEB5α Cloning strain New England Biolabs 
BL21(DE3) BL21  derivative for protein expression Novagen 
Plasmids 
pET2817 pET28a derivative for overexpression of N-terminally His-tagged proteins  (AmpR) (Eckert et al., 2006). 
pGhost9 Thermosensitive plasmid for targeted gene replacement in E. faecalis (ErmR) P. Serror 
pZXL5 Thermosensitive plasmid for transposon mutagenesis (GmR) (Zhang et al., 2012b) 
pJEH11 Replicative plasmid for E. faecalis complementation experiments (ErmR) M. Arthur 
pET-AdmA pET2817 derivative expressing AdmA (residues 26 to172) This work 
pTetH Replicative plasmid for complementation experiments (ErmR) Lab stock 
pAtlA_WT pTetH derivative encoding a tetracycline-inducible wild-type atlA allele This work 
pAtlA_E212Q pTetH derivative encoding a tetracycline-inducible atlA_E212Q allele This work 
pAtlA_LysM pTetH derivative encoding a tetracycline-inducible LysM domain This work 
pAtlA_WT pTetH derivative encoding a tetracycline-inducible wild-type atlA allele This work 
pSecA_WT pTetH derivative encoding a tetracycline-inducible wild-type secA allele This work 
pSecA_DE377 pTetH derivative encoding a tetracycline-inducible secA_DE377 allele This work 
pSecA_R548H pTetH derivative encoding a tetracycline-inducible secA_R548H allele This work 
pSecY_WT pTetH derivative encoding a tetracycline-inducible wild-type secY allele This work 
pSecY_L337S pTetH derivative encoding a tetracycline-inducible secY_L337S allele This work 






































a AmpR, resistant to ampicillin; ErmR, resistant to erythromycin;  
Table  4. Bacterial strains, plasmids and oligonucleotides 
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2.5. Growth conditions 
2.5.1. E. faecalis 
2.5.1.1. Routine cultures of E. faecalis.  
Strains were streaked from glycerol stocks and grown on BHI-agar plates. Plates were stored 
for up to two weeks at 4°C for short-term storage, before being re-streaked from glycerol 
stocks. For long-term storage, a single colony was spread onto a BHI agar plate containing 
relevant antibiotics and grown overnight at 37°C. A loopful of cells was re-suspended in 2 × 
1mL BHI containing 15% (v/v) glycerol in a sterile 1.5 mL microfuge tube. These glycerol 
stocks were stored at -80°C. Liquid cultures were prepared by inoculation of culture medium 
with a single isolated colony. Unless otherwise stated, cultures were grown overnight in 
sterile plastic 25 mL universals or conical flasks without agitation.  
E. faecalis plates or liquid medium cultures were grown at 37°C unless otherwise stated.  
2.5.1.2. Selection of spontaneous mutants in semi-solid medium 
THY broth - agar 0.06% (m/v) was poured into 250 mL cell culture flasks and left at 4°C for 
1h to set before inoculation with dilutions of pre-cultures made overnight in BHI suitable to 
see individual colonies. The cells were grown at 37°C without agitation and the appearance of 
spontaneous mutants with altered colony morphology followed over a period of 96h 
2.5.1.3. Analysis of sedimentation profiles in standing cultures 
A falcon tube (15 mL) containing 6 mL of a BHI broth medium was inoculated with a single 
colony of E. faecalis. The tubes were then incubated overnight (O/N) at 37°C without 
agitation before taking a picture of all tubes.  
 
2.5.2. Micrococcus luteus 
M. luteus cells were grown in BHI at 37°C with agitation at 250 rpm. Alternatively, freeze-
dried M. luteus ATCC46498 was purchased from Sigma, resuspended in dH2O and 
autoclaved. Cells were incorporated in BHI agar plates at a final OD600 between 0.5 and 2.5. 
 
2.5.3. Escherichia coli 
E. coli strains were grown at 37oC in LB media eventually supplemented with antibiotics to 
ensure selection of plasmids. Plate cultures were stored at 4oC for up to two weeks before re-
streaking from glycerol stocks. Strain storage, inoculation of medium and growth cultures 





2.6. Buffers and stock solutions 
All buffers were prepared using milliQ water and stored at room temperature unless stated. 
Solutions for use in microbiological work and molecular biology experiments were sterilised 
by autoclaving (20min, 121⁰C, 15 psi).  
 
2.6.1. 10× DNA loading buffer  
Bromophenol blue 0.25% (w/v) 
Glycerol  50% (v/v) 
 
2.6.2. Phosphate buffered saline (PBS) 
NaCl  8 g/L 
Na2HPO4  1.4 g/L 
KCl  0.2 g/L 
KH2PO4  0.2 g/L  
The pH was adjusted to 7.4 using NaOH. 
 
2.6.3. TAE (50x)  
Tris Base   242 g/L 
Acetic acid   0.57% (v/v)  
EDTA (pH 8.0) 0.05M  
1× TAE buffer was made by diluting 50× TAE buffer 1:50 with dH2O. 
 
2.6.4. SDS-PAGE solutions 
 
2.6.4.1. 4× SDS-PAGE loading buffer 
Tris-HCl (pH 6.8) 0.25 M 
SDS 20 % (w/v) 
Glycerol 40 % (v/v) 
Bromophenol blue 0.4 % (w/v) 
β-mercaptoethanol (βME) was added just before use at a concentration of 50mM. 
1× SDS-PAGE loading buffer was made by diluting 4× SDS-PAGE buffer 1:4 with dH2O 
 
2.6.4.2. SDS-PAGE 
10% (w/v) Resolving gel 
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1.5 M Tris-HCl (pH 8.8)  2.5 mL 
10% (w/v) SDS 100 µL 
30% (w/v) Acrylamide/Bis (37.5:1) 4.0 mL 
10% (w/v) Ammonium persulphate 50 µL 
TEMED (N,N,N’N’-tetramethyl-ethylenediamine) 10 µL 
dH2O  3.5 mL 
The components were mixed by gentle swirling and loaded into the gel casting apparatus 
using a 10 mL pipette. A layer of isobutanol was carefully pipetted on top of the gel to isolate 
it from the air. After the gel had solidified, the stacking gel was made up as follows; 
4% (w/v) Stacking gel  
0.5 M Tris-HCl (pH 6.8) 2.5 mL 
10% (w/v) SDS 100 µL 
30% (w/v) Acrylamide/Bis (37.5 : 1) 1.3 mL 
10% (w/v) Ammonium persulphate 50 µL 
TEMED (N,N,N’N’-tetramethyl-ethylenediamine) 10µL 
dH2O  6.1 mL 
The components were mixed by gentle swirling and pipetted on top of the resolving gel. A 
plastic comb was inserted into the gel to create wells. After the gel had solidified, it was 
transferred to the gel-running tank and submerged in 1× SDS-PAGE electrophoresis buffer. 
 
2.6.4.3. 10× SDS-PAGE electrophoresis buffer 
Glycine  144 g/L 
Tris base  30.3 g/L 
SDS  10 g/L 
1× SDS-PAGE buffer was made by diluting 10× SDS-PAGE buffer 1:10 with dH2O. 
 
2.6.4.4. Coomassie Blue staining solution 
Coomassie Blue R-250 0.25% (w/v) 
Acetic acid  10% (v/v) 
Methanol  50% (v/v) 





2.6.4.5. Destain solution 
Acetic acid  10% (v/v) 
Methanol  5% (v/v) 
 
2.6.4.6. Zymogram solutions renaturing solution  
Triton X-100  0.2 % (v/v) 
NaCl  50 mM 
Depending on the pH, the following buffers were used: 
50 mM Citrate      pH 5.0 
50 mM HNa2PO4     pH 6.25 
50 mM Tris-HCl     pH 7.4 
50 mM Tris-HCl     pH 8.4 
 
2.6.5. TE 
Tris-HCl      100 mM 
EDTA       10 mM 
The pH was adjusted to 7.5 using 1M HCl before autoclaving. 
 
2.6.6. Solutions to prepare E. coli competent cells  
RF1 
RbCl  1.2 g 
MnCl2.4H2O  9.9 g 
Potassium acetate 30 mL of 1M stock (pH 7.5) 
CaCl2·2H2O  1.5 g 
Glycerol  150 mL 
The constituents were dissolved in 800 mL sterile dH2O and the pH was adjusted to 5.8 using 
0.2 M acetic acid before made up to 1 L. The solution was filter sterilized and stored at 4°C. 
RF2 
MOPS  20 mM of 0.5M stock (pH 6.8) 
RbCl  1.2 g  
CaCl2.2H2O  11 g 
Glycerol  150 mL 
The constituents were dissolved in 800 mL sterile dH2O and the pH was adjusted to 6.8 using 




Sucrose       0.5 M 
Glycerol      10% (v/v) 
The pH was adjusted to 7.0 using 1M HCl before autoclaving. 
 
2.6.8. SM17MC 
SM17MC corresponds to M17-Glu supplemented with: 
Sucrose       0.5 M 
MgCl2      10 mM 
CaCl2      10 mM 
The pH was adjusted to 6.9 using 1M HCl before filter-sterilization. 
 
2.7. Molecular biology techniques 
2.7.1. Polymerase chain reaction (PCR) 
2.7.1.1. High-fidelity PCR using Phusion DNA polymerase (Thermofisher Scientific)  
Phusion DNA polymerase was utilised when high sequence fidelity was required, such as 
when DNA was being used for cloning. Reactions were performed in a Biorad T100 thermal 
cycler. 25μl 2x Phusion master mix was mixed with an amount of 0.4μM of each 
oligonucleotide and template of DNA was (10-100 ng) in a final volume of 50μl. 2.5μl 
DMSO was added when necessary. The PCR machine was pre-set as follows: 
 1. Initial denaturation set up: 98 °C for 10 s     
  2. Denaturation set up: 98 °C for 10 s    
  3. Annealing set up: 56 °C for 20 s (reduced to 50 °C if necessary) 
  4. Extension time: 72 °C for 15-30s per kilobase   
  5. Repeat steps between 2- 5 30 cycles    
  6. Final extension set up: 72 °C for 5 minutes    
 
2.7.1.2. Routine PCR Taq DNA polymerase  
When high sequence fidelity was not necessary, such as when screening plasmids for inserts, 
Taq polymerase was used. Reactions were carried out in a Biorad T100 thermal cycler. 10μl 
taq master mix (lab stocks) was mixed with 0.4μM of each oligonucleotide and part of an E. 




 1. Initial denaturation time: 90 °C for 5 minutes    
 2. Denaturation temperature and time: 94 °C for 20 s   
 3. Annealing temperature and time: 56 °C for 20 s    
 4. Extension temperature and time: 72 °C for 1 minute per kilobase  
 5. Repeat steps between 2- 5 for 30 cycles     
 6. Final extension temperature and time: 72 °C for 5 minutes 
 
2.7.2. PCR purification  
PCR products were purified using a GeneJET kit (Fisher Scientific), according to the 
manufacturer’s instructions. An equal volume of binding buffer was added to the PCR 
product. The DNA solution was applied to the column and centrifuged at 13,000 × g for 
30 sec. The flow-through was discarded and the column placed back in the same collection 
tube. The column was washed twice with 0.75 mL Buffer PE by centrifugation (as before). 
The flow-through was discarded and the column placed back in the same collection tube and 
centrifuged (13,000 × g) for 2 min. The column was placed in a clean micro centrifuge tube to 
elute the DNA by adding 30 µL TE. The concentration of the eluate was determined by 
measuring the absorbance at 260 nm using a Nano-drop device and stored at -20 °C until 
further use. 
 
2.7.3. Gel extraction  
The DNA was excised from an agarose gel with a clean, sharp scalpel and purified using a 
GeneJET kit (Fisher Scientific), according to the manufacturer’s instructions.. The gel slice 
was weighed and 3 volumes of binding buffer were added. The mixture was then applied onto 
the column and the washing and elution steps carried out as previously described above (see 
2.7.2).  
 
2.7.4. Plasmid purification 
Plasmid DNA was purified following alkaline lysis using a GeneJET kit (Fisher Scientific). 
Briefly, the pellet corresponding to 3 mL of an overnight culture in LB was re-suspended in 
250μl of resuspension buffer (50mM Tris-HCl [pH 8.0], 50mM EDTA, RNase A 
100 µg/mL). 250μl of lysis buffer (1% [m/v] SDS, 0.2 M NaOH) was added, the tube mixed 
by inversion 4-6 times and incubated for 5 min at room temperature. 350μl of neutralisation 
buffer (3 M potassium acetate [pH 5.5]) was added and the tube mixed thoroughly by 
inverting until the precipitation was evenly dispersed. 
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The solution was centrifuged for 10min at 15,000 x g) and the supernatant applied to a spin 
column. The DNA was subsequently purified according to the manufacturer’s instructions 
(see 2.7.2). 
 
2.7.5. Genomic DNA extraction 
Genomic DNA was isolated and purified from E. faecalis using a QIAGEN DNeasyTM kit 
according to the manufacturer’s instructions. A single colony of E. faecalis was used to 
inoculate 5 mL of BHI in a 30 mL sterile universal tube and grown overnight at 37°C. 1.5 mL 
of cells was harvested by centrifugation (4,000 rpm, 5 min, room temperature). Cells were re-
suspended in 180 µl enzymatic lysis solution containing 50 mM phosphate buffer (pH 6.0,) 50 
mM EDTA, 10 mg/mL RNase and 5 µL mutanolysin (5 mg/mL). After 1h incubation at 37°C, 
the protocol was continued as per the manufacturer’s instructions. Genomic DNA was eluted 
into clean 1.5 mL microfuge tubes using two 200 µL aliquots and the two eluates were 
pooled. The DNA concentration was estimated using a Nano-drop device and stored at 4°C 
until further use. 
 
2.7.6. Enzymatic digestion of DNA 
Digestion of DNA was performed according to the manufacturer’s instructions, with the 
buffers supplied in volumes. Analytical digestions (to check plasmid maps) were made using 
200 ng of DNA in a final volume of 15 µL in the presence of 4 units of each enzyme. 
Preparative digestions (to generate vectors or insert for ligation or Gibson assembly) were 
made using 5µg of DNA in a final volume of 50 µL in the presence of 30 units of each 
enzyme. The reaction volume was made up with dH2O. The restriction digests were incubated 
at 37°C for 45 minutes (PCR products or plasmids) or 1h30 in the case of genomic DNA.  
 
2.7.7. DNA ligation 
Each ligation reaction contained approximately a 1:3 molar ratio of vector to insert. The final 
ligation volume (15 µL) contained 100ng of vector, an appropriate amount of insert (variable 
depending on the size), 1.5 µl 10× DNA ligase buffer, and 200 µL of T4 DNA ligase. The 
final volume was made up to 15 µl with sterile MilliQ water and incubated overnight at 16°C. 






2.7.8. Gibson assembly 
Restriction-free cloning was carried out using the Gibson Hi-Fi assembly kit (NEB) according 
to the manufacturer’s instructions. Oligonucleotides were designed to amplify the insert using 
Snapgene. They contained 32 bases homology with the vector. 100 ng of vector DNA cut by 
restriction enzymes was incubated in the presence of PCR-amplified insert (1:3 molar ratio of 
vector to insert) in a volume of 4 µL before adding an equal volume of NEB Hi-Fi 2x 
mastermix. The reaction was incubated for 30 minutes at 50°C and 4 µL were directly used to 
transform electro- or chemically-competent E. coli cells. 
 
2.7.9. Agarose gel electrophoresis 
DNA fragments were separated by horizontal gel electrophoresis using various size 
electrophoresis tanks (Fisher Scientific). Appropriate volume of agarose gel (1% [w/v]) was 
dissolved in TAE by microwaving. For the visualisation of DNA, ethidium bromide was 
added to the melted agarose at a final concentration of 0.5µg/mL. DNA loading dye was 
added to a 1× final concentration with the samples before loading in the gel wells. The gel 
was run at 5V/cm for 1h and visualised using a UV transilluminator at 305 nm. To estimate 
the sizes of DNA fragments, DNA markers were also loaded onto the gel. 
 
2.7.10. Agarose gel photography 
A record of agarose gels was obtained by photographing the UV- illuminated gels using 
BioDoc-It system (UVP) and printed by Sony Video Graphic Printer using Thermal Print 
Media (UPP-110HA). 
 
2.8. Spectrophotometric measurement (OD600) 
To follow bacterial growth, spectrophotometric measurements at 600 nm (OD600) were 
performed using a Fisher Scientific spectrophotometer. When necessary, the culture samples 
were diluted in unused sterile corresponding culture medium to give a reading within the 
range of this type of spectrophotometer. 
 
2.9. Protein expression and purification 
2.9.1. Expression of recombinant proteins in E. coli BL21(DE3) 
Recombinant plasmids (pET2817 derivative) were used to transform E. coli BL21(DE3). A 
starter culture was prepared by inoculating 15 mL of LB containing Ampicillin (100 µg/mL) 
in a universal tube. 
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The culture was incubated at 37°C with shaking (250 rpm) overnight. 7.5 mL of the starter 
culture was added to 750 mL LB containing ampicillin (100 µg/mL) in a 3L flask, and 
incubated at 37°C with shaking (250 rpm) until OD600 0.7. At this stage, IPTG was added at a 
final concentration of 1 mM, and incubation continued for 4 h. Cells were harvested by 
centrifugation (6,000 × g, 15 min, 4°C). Supernatant was discarded and the pellet stored at -
70°C. 
 
2.9.2. Preparation of protein extracts 
Induced cells were thawed and re-suspended in 25 mL of buffer A (50 phosphate buffer 
[pH 7], 250 mM NaCl, 20% glycerol (v/v), and 2mM DTT). A crude extract was prepared by 
sonication on ice using setting 10 for 5 cycles (25 sec on, 30 sec rest). An aliquot was taken 
and the rest of the lysate was centrifuged at 45,000 × g for 20 min at 4°C. The protein 
concentration in the soluble fraction was determined using the protein Bio-Rad assay 
according to the manufacturer’s instructions, with BSA as a standard. The concentration of 
the crude extract was assumed to be the same as the one of the soluble fraction. Protein 
samples were prepared at a concentration of 1 mg/mL and heated for 3 min at 95°C before 
being loaded on an SDS-PAGE. 
 
2.9.3. Protein purification using immobilized metal affinity chromatography (IMAC) 
Two mL of Ni-NTA resin (Qiagen) was washed in distilled water and equilibrated twice with 
12 mL of buffer A (see 2.9.2). The soluble fraction was incubated in the presence of the 
equilibrated beads in a 50 mL Falcon tube for 1h at 4°C under agitation. His-tagged proteins 
were purified “in batch” once transferred into a 15 mL Falcon tube using a centrifuge. After 
centrifugation of the loaded beads, the fraction containing proteins not bound to the resin was 
recovered (flow through). The beads were then washed successively four times with 13 mL of 
buffer A, twice with 13 mL of buffer A (see 2.9.2) with 5 mM imidazole and eluted with 10 
mL of buffer A with 400 mM imidazole (twice 3 mL and twice 2 mL). The elution fractions 








2.9.4. Protein purification using size exclusion chromatography 
Proteins from IMAC purification were loaded on a Superdex 75 26/60 chromatography 
column (GE Healthcare) pre-equilibrated in buffer A and eluted with an isocratic gradient. 
The proteins with the expected retention time were pooled and the concentration calculated 
using the value predicted by the Expasy server (web.expasy.org/protparam/). 
 
2.10. Preparation of cell walls as a substrate in agar plates 
2.10.1. M. luteus cells 
See section 2.5.2. 
2.10.2. E. faecalis cells 
To increase the sensitivity of the assay for PG hydrolase activity, we used a mutant with 
multiple deletions in pbp genes (D4; DponADpbpFDpbpZDpbp5) [M. Arthur, unpublished 
results]. Large volume cultures (4.5L in 5L flasks) were grown in BHI broth (OD600 ~ 2.5) 
O/N at 37°C. Cells were harvested (7,500 x g for 10 min at 4°C), re-suspended in 35mL of 
dH2O and autoclaved. 
 
2.10.3. Unbroken cell walls 
Cells corresponding to 1.5 L of culture were boiled in 4% (w/v) SDS for 30 min in a total 
volume of 25 mL, washed 6 times in dH2O, re-suspended in 10 mL of dH2O and autoclaved. 
 
2.10.4. E. faecalis broken cells 
D4 mutant cells corresponding to 3 L of culture were re-suspended in 20 mL of dH2O and 
broken by 3 passages through a French press at a pressure of 1,000 psi. Broken cells were 
recovered by centrifugation (45,000 x g, 20 min, 20°C), washed 3 times with dH2O, re-
suspended in 10 mL of dH2O and autoclaved. 
 
2.10.5. Preparation of broken cell walls  
Broken cells (see 2.10.4.) were boiled in 4% (m/v) SDS for 30 minutes min in a total volume 








2.11. Sodium Dodecyl Sulphate-Polyacrylamide gel electrophoresis (SDS-PAGE) 
2.11.1. SDS-PAGE 
Discontinuous SDS-PAGE was performed using Bio-Rad minigels (70 mm (L) × 80 mm (W) 
× 1 mm thickness) following the manufacturer’s instructions (Bio-Rad). Reagents for SDS-
PAGE were prepared as described in (Chapter 2.6.). The resolving and stacking gel contained 
10% (w/v) and 4% (w/v) acrylamide respectively. Samples were prepared in sample buffer 
and heated at 95°C for 5 min. Electrophoresis was performed at RT with constant voltage of 
190 V for 50 min. 
 
2.11.2. Coomassie blue staining 
After electrophoresis, protein gels were placed in approximately 30 mL Coomassie blue stain 
for 30-60 min and destained in two volumes of approximately 30 mL destain solution 
(Chapter 2.6.) overnight. Molecular masses were determined by comparison to a molecular 
mass protein marker of known sizes. 
 
2.11.3. Renaturing SDS-PAGE 
PGH activity was detected by renaturing gel electrophoresis using purified cell walls as the 
substrate then incorporated into the acrylamide gel to a concentration corresponding to an 
OD600 between 0.5-3 (see result section). Electrophoresed gels were rinsed three times 5 min  
in 250 mL dH2O to remove SDS and then in 200 mL of renaturing solution (chapter 2.6.) at 
RT for 30 min, followed by incubation overnight at 37°C in another 200 mL of renaturing 
solution. After de-staining in dH2O, PGHs activity was visualised as zones of clearing in the 
opaque background. Molecular masses were determined by comparison to protein standards 
of known sizes that were run on the same gel, cut off and Coomassie blue stained.  
 
2.11.4. Protein sample preparation for zymogram analysis 
Protein samples were prepared from 10 mL of an overnight standing culture. Bacterial pellets 
were re-suspended in 600 µL of PBS and 250µl of glass beads (106µm in diameter). The cells 
were broken using a Fast Prep machine (6.5 speed, 5 cycles of 30 seconds with 2 min pauses 
between each cycle to avoid heating). Protein concentration was measured 
spectrophotometrically at 595nm using a Bio-Rad protein assay kit. Protein samples were 





2.12. Isolation of transposon mutants impaired in AtlA activity 
The screening for the transposon mutants was performed on an agar plate containing M. 
luteus. Mutants did not have a halo around the clones on M. luteus plates were isolated, 
interrupted genes were identified by reverse PCR. 
 
2.12.1. Construction of the transposon library 
pZXL5 was introduced into E. faecalis by electroporation. Transformants harbouring pZXL5 
were selected on BHI agar plates containing 128 mg/mL gentamycin (Gm128) and 10 mg/mL 
chloramphenicol (Cm10) at a permissive temperature (28°C). A transformant was grown 
overnight in 200 mL BHI broth containing Gm128 and Cm10 at 28℃. Transposition was 
induced by inoculating 200µl of the overnight culture in 200mL of BHI broth containing 
Gm128 supplemented with nisin (25ng/mL). This culture was incubated overnight at 42℃. The 
nisin-induced culture containing transposon mutants was used to inoculate BHI broth (200µl 
in 200mL) containing Gm128 and incubated at 42℃  
 
2.12.2. Identification of atlA deficient mutants 
Transposon mutants were plated on BHI agar plates containing Gm128 and M. luteus as a 
substrate. 300 colonies per plate was found to be the optimal density; this corresponds to 
plating 100µl of a 10-3 dilution of the library (Fig. 49).  
 
2.12.3. Mapping of the transposon insertions sites 
The transposition site was identified by reverse-PCR using self-ligated chromosomal DNA 
that had been digested by SspI and two divergent primers on the transposon. The detailed 
experimental strategy is described in the result section (see 3.2.3.2, Fig. 53). 
 
2.13. rp-HPLC analysis of peptidoglycan structure 
2.13.1. Purification of cell walls 
Unbroken cell walls were extracted from 500 mL of exponentially growing culture 
(OD600=0.7) as described in section 2.10.3. The material was further treated with 2 mg/mL 
pronase for 5h at 60°C and washed 6 times with MilliQ water. Insoluble, protease-treated cell 






2.13.2. Preparation of disaccharide-peptides 
One mg of purified cell walls was digested by mutanolysin (0.25 mg/mL) in a final volume of 
100 µL containing 50 mM phosphate buffer (pH 6.0) for 16h at 37°C. The digestion mixture 
was heated for 5 min at 95°C to inactivate mutanolysin and soluble disaccharides-peptides 
were recovered by centrifugation (20,000 xg, room temperature, 10 min). Soluble 
muropeptides were reduced by addition of 100 µL of 250 mM borate buffer (pH 9.0) and 
2 mg/mL of sodium borohydride. After 20 min at room temperature, the pH was adjusted at 
4.5. 
 
2.13.3. rp-HPLC separation of disaccharide-peptides 
20 µL of soluble, reduced muropeptides (ca. 100 µg) were analysed by rp-HPLC on a Dionex 
Ultimate 3000 system. Following injection on a Hypersil GOLD aQ column (C18; 2.1 by 200 
mm, Thermo Scientific), muropeptides were separated at a flow rate of 0.3 mL/min using 
10 mM ammonium phosphate (pH 5.5) as a mobile phase (buffer A). After a 5 min isocratic 
step, muropeptides were eluted with a 45 min methanol gradient (0 to 30% linear gradient in 
buffer A). Elution was monitored by recording the Absorbance at 210 nm. 
 
2.14. Transformation techniques 
2.14.1. Transformation of E. coli  
2.14.1.1. Preparation of E. coli competent cells (Hanahan, 1983) 
1 L of pre-warmed LB medium in a 3 L conical flask was inoculated with 5 mL of an 
overnight culture and incubated at 37°C with shaking (250 rpm), until an OD600 of 0.5 - 0.8 
was reached. The culture was transferred into a 1 L bottle and chilled on ice for 15 min. The 
cells were then harvested by centrifugation (6,500 x g, 10 min, 4°C), and the pellet was 
drained before re-suspended in 16 mL RF1 (chapter 2.6.9) and incubated on ice for 15 min. 
The cells were pelleted again, drained as before, re-suspended in 4 mL RF2 (chapter 2.6.9) 
and placed on ice for 15 min. The cells were divided into 50 µL aliquots and used 
immediately or the microfuge tubes were snap frozen in liquid nitrogen before storage at -
80°C. The level of competence of the cells was determined by transformation with a 10 pg of 







2.14.1.2. Transformation of Hanahan competent E. coli cells by heat-shock 
An aliquot of frozen Hanahan competent cells was thawed on ice for 10 minutes before 
adding 4µl of the ligation or Gibson assembly product. After 30 min on ice, the mixture was 
heat shocked at 42°C for 30 sec and immediately returned to the ice for a further 5 min. The 
volume was made up to 1 mL with SOC broth and the transformed cells were incubated for 1 
hr at 37°C with shaking at 250 rpm to allow expression of plasmid-encoded antibiotic 
resistance markers. Transformed cells were spread using sterile glass beads onto agar plates 
containing appropriate antibiotics and incubated at 37°C for 18-48 h.   
 
2.14.2. Transformation of E. faecalis 
2.14.2.1. Preparation of E. faecalis electro-competent cells 
A single colony of E. faecalis was used to inoculate 10 mL of BHI broth and incubated 
overnight at 37°C without shaking. This culture was used to inoculate 200 mL of fresh pre-
warmed SGM17 in a 250 mL conical flask to an OD600 of 0.05 and grown at 37°C without 
shaking until log phase (OD600 0.5-0.6). Cells were harvested by centrifugation (5,000 x g, 
10 min, room temperature) and washed 3 times with 50 mL of cold Suc-Gly buffer. Cells 
were finally re-suspended in 500 µL of Suc-Gly and snap-frozen in 50 µl aliquots using liquid 
nitrogen and stored at -80°C. The level of competence of the cells was determined by 
electroporation with 10ng of pAT18 as a control plasmid. 
 
2.14.2.2. Transformation of E. faecalis by electroporation 
0.2-1 µg of plasmid DNA dialysed against MilliQ water to ensure the complete removal of 
salt. The DNA was then added to an aliquot of electro-competent cells, which had been 
thawed on ice for 5 min and added to a chilled 1 mm electroporation cuvette. The plasmid/cell 
mix was electroporated at room temperature at 200 ohms, 25 µF and 2.4 kV using a Bio-Rad 
Gene Pulser. Cells were recovered by adding 1 mL of cold SM17MC buffer and kept 5 min 
on ice before incubation for 3 h at 28°C (pGhost derivatives) or 37°C (non-thermosensitive 
plasmids). Cells were spread on selective media as described above and incubated at 28°C or 





3.1. Isolation and characterization of spontaneous mutants with altered AtlA activity 
3.1.1. Experimental strategy to isolate mutants forming long chains in semi-solid media 
 
The screening used was based on the sedimentation properties of Enterococcus faecalis cells. 
This screen was previously also used with Lactococcus lactis to identify mutants with 
impaired septum cleavage (Mercier et al., 2002) during division. A flask containing THY 
broth (Todd Hewitt containing 5% [m/v] yeast extract) supplemented with a low 
concentration of agar (0.06% (m/v)) was inoculated with diluted pre-cultures of the wild type 
or its isogenic mutant (atlAE212Q-gfp) to see individual colonies. The cells were grown at 37°C 
without agitation and the appearance of spontaneous mutants with altered colony morphology 
followed over a period of 96h (Fig. 29A). The corresponding mutants were isolated and 
analysed. 
E. faecalis wild type cells are typically found as diplococci or form short chains (4 to 6 cells), 
they form “comets” as they grow in semi solid medium (Fig. 29B); however, atlA mutants 
form long chains and are immobilized in the medium and they appear as “clumps” (Fig. 29C). 
 
 
Figure 29. Strategy used to isolate spontaneous mutants with altered chain forming phenotypes. 
(A), A flask containing semi-solid medium was inoculated with E. faecalis cells and incubated at 37°C 
without agitation. Arrows show colonies growing in the medium. (B), Wild type colonies made of 
diplococci and short chains form “comets” as they are mobile in the semi-solid medium. (C), atlA 




3.1.2. Identification of mutants with impaired septum cleavage 
3.1.2.1. JH2-2 mutants forming long chains 
After several attempts, it was not possible to isolate spontaneous mutants forming long chains 
from the wild type strain E. faecalis JH2-2 (Fig. 30A). Although AtlA mutants form 
distinctive colonies in the semi solid media (Fig. 29C), it is possible that the appearance of 
colonies forming clumps is not easy to see in the background formed by wild type comets. 
Another possibility is that we did not screen enough colonies to identify an AtlA mutant.  
 
3.1.2.2. atlA derivatives forming very long chains (group A) 
As an alternative strategy, we decided to use an atlA mutant forming long chains as a parental 
strain. We used a JH2-2 derivative (called atlAE212Q-gfp) expressing inactive AtlA allele with a 
point mutation in the catalytic residue (substitution of glutamic acid in position 212 by a 
glutamine; fused to the GFP. We isolated 4 mutants forming more compact colonies than the 
parental atlAE212Q-gfp strain. These mutant were defined as group A mutants (Fig. 30BA). 
 
3.1.2.3. Mutants supressing the long chain phenotype of group A mutants (group B) 
One of the group A mutants (clone 14) was selected to isolate suppressor mutations leading to 
the formation of shorter chains again. Nine derivatives were isolated; defining group B 
mutants (Fig. 30C). 
 
3.1.2.4. Mutants supressing long chain phenotype from atlAE212Q-gfp mutants (group C) 
We also tried to identify mutants that suppress the atlA phenotype (forming short chains from 
an atlAE212Q-gfp strain forming long chains) unlike strain atlAE212Q-gfp that is immobile and 
forms clumps, suppressor mutants restored a WT phenotype and formed comets in the semi-
solid medium. Twenty one derivatives forming short chains were isolated and named group 


























Figure 30. Description of the screen used to isolate spontaneous E. faecalis in semi-solid medium. 
(A), No JH2-2 derivatives forming long chains were isolated. (B), Identification of atlAE212Q-gfp 
derivatives forming very long chains (class A mutants). (C), Identification of class A derivatives 
(clone 14) forming short chains. (D), Identification of atlAE212Q-gfp derivatives forming short chains. 
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3.1.3. Analysis of the sedimentation profiles of E. faecalis mutants 
The size of cell chains has an influence on the sedimentation profile of the culture. This 
property was therefore used as a method to compare the sedimentation profiles of the 
spontaneous mutants isolated in comparison to the wild type. A falcon tube containing a BHI 
broth medium was inoculated with the E. faecalis cells and incubated overnight (O/N) at 37°C 
without agitation. The results corresponding to the control strains are shown in (Fig. 31). 
Wild-type cells forming essentially diplococci did not sediment and the corresponding culture 
was homogeneously turbid with most cells in suspension (planktonic growth; (Fig. 31A). A 
mutant with a deletion in two genes encoding autolysins previously described (AtlB and AtlC; 
∆BC) showed a sedimentation profile very similar to WT with planktonic growth (Fig. 31B). 
By contrast, the strains harbour an atlA mutation (either the atlAE212Q-gfp mutation or the atlA 
deletion) sedimented (Fig. 31C), the triple deletion mutant DABC (Fig. 31D) showing the 
most extreme sedimentation. 
 
 
Figure 31. Sedimentation profiles of E. faecalis control strains.  Falcon tubes containing BHI broth 
were inoculated with controls strains and grown O/N at 37°C without agitation. (A), wild type JH2-2 
strain (WT) essentially forms diplococci and short chains that do not sediment (planktonic growth). 
(B), the double DatlB DatlC mutant strain (∆BC) displays a sedimentation profile similar to the WT 
strain, indicating that when AtlA is produced, the enzymatic activities of AtlB and AtlC do not 
contribute significantly to septum cleavage. (C), the atlAE212Q-gfp mutant forms long chains that 
sediment at the bottom of the tube. (D), the ∆ABC mutant forms extremely long chains and shows a 







The spontaneous mutants isolated were analysed using the same strategy as described above 
and their sedimentation profiles are shown in (Fig. 32). 
Three of the 4 clones in group A (5, 9 and 20) had a more pronounced sedimentation than the 
wild type, as expected, clone 9 having a similar profile as the ∆ABC  mutant.  Clone 14 was 
similar to the parental strain. 
 
Most of the clones in group B, suppressing the long chain-forming phenotype of mutant 14 
presented more planktonic growth than the parental strain. Surprisingly, mutants 23, 25 and 
30 had sedimentation profiles similar to the parental mutant 14 (Fig. 32). 
 
All mutants from group C were isolated based on their mobility in semi-solid medium greater 
than the atlAE212Q-gfp strain. As expected for mutants forming shorter chains than the atlA 
mutant, most of the group C mutant cultures appeared more turbid than the parental ∆atlA 
strain (more planktonic growth). Mutants 97, 98, 01, 03, 07, 08, 19 and 21 displayed a 
sedimentation profile similar to the wild type JH2-2 strain with a planktonic growth. A second 
set of mutants 99, 4, 6, 10, 11, 12, 13, 15, 16, 17 and 18 showed no obvious difference with 
their parental strain atlAE212Q-gfp. A third set of mutants 00 and 02 showed surprisingly more 





Figure 32. Sedimentation profiles of spontaneous mutants in BHI standing cultures. In group A 
mutants, sedimentation associated with clone 14 was similar to the parental strain whilst other mutants 
(clones 5, 9 and 20) showed a more pronounced sedimentation. In group B mutants, sedimentation 
profiles of clones 23, 25 and 30 were similar to that of the parental strain (clone 14) whilst the other 
mutants (22, 24, 26, 27, 28 and 29) showed more planktonic growth indicating that they formed 
smaller cell chains. In group C mutants, clones 97, 98, 01, 03, 07, 08, 19 and 21 were similar to the 
planktonic growth of the wild type. Mutants 99, 4, 6, 10, 11, 12, 13, 15, 16, 17 and 18 showed no 
obvious difference with the parental atlAE212Q-gfp strain. Mutants 00 and 02 showed a more 






3.1.4. Detection of hydrolytic activities PGHs produced by mutants on agar plates 
 
3.1.4.1. Detection of AtlA activity on M. luteus agar plates 
The PGH enzymatic activity at the surface of the cells can be visualized on agar plates that 
contain autoclaved cells as a substrate. In E. faecalis, AtlA activity can be specifically 
detected using M. luteus cells as a substrate. The hydrolysis of M. luteus autoclaved cells 
leads to the formation of a halo formed around the colonies, indicating that the enzymes are 
also able to diffuse in the medium. It has been shown that AtlA is the only PGH produced by 
E. faecalis able to hydrolyse M. luteus cells as colonies from the atlA mutant are not 
surrounded by any halo (Qin et al., 1998). 
 
To compare the activity of the spontaneous mutants isolated with that of the control strains, 
all strains were grown in 96-well plates. Cells were grown overnight at 37°C and inoculated 
at the surface of agar media that containing M. luteus autoclaved cells with a 96-pin 
replicator. The following strains were used as controls: 
- JH2-2, a wild-type strain (WT); 
- ∆atlA (∆A), a mutant harbouring an in-frame deletion of the atlA gene; 
- atlAE212Q-gfp, the catalytically inactive mutant used for our screen. 
- A-GFP, a JH2-2 derivative expressing a translational fusion between AtlA and the GFP; 
- ∆atlB∆atlC (∆BC), a JH2-2 derivative with in frame deletion in the two genes encoding 
the PGHs AtlB and AtlC;  
- ∆atlA∆atlB∆atlC (∆ABC), a JH2-2 derivative with in frame deletion in the genes encoding 
the PGHs AtlA, AtlB and AtlC. 
As expected, halos were observed around colonies of the WT, A-GFP, and ∆BC strains 
which produce an active AtlA (Fig. 33A). No halo was detected around the colonies of 
strains ∆A, atlAE212Q-gfp and ∆ABC, confirming that AtlA is the only autolysin produced by 
E. faecalis that can hydrolyse M. luteus peptidoglycan (Fig. 33A). None of the spontaneous 
mutants isolated so far formed a halo on M. luteus plates, even after long incubation after 
(48h) (Fig. 33B) and after (72h) (Fig. 33C). This result indicated that the increased septum 
cleavage activity of mutants in group B and C was not due to a reversion of the mutation, 
atlAE212Q-gfp present in the parental strain or to the expression of another PGH which can 




Figure 33. Detection of AtlA hydrolase activity on plates containing M. luteus cells after 24 
hours (A), 48 hours (B) or 72 hours (C). Control strains (boxed) include the atlA deletion mutant 
(∆A), JH2-2 (WT), the atlAE212Q-gfp parental strain, a JH2-2 derivative expressing an AtlA-GFP 




3.1.4.2. Detection of PGH activities on E. faecalis agar plates 
We further analysed the surface-associated PGH activities of the spontaneous mutants 
isolated using E. faecalis autoclaved cells as a substrate. Previous studies revealed that this 
substrate was suitable to detect AtlA, AtlB, and AtlC activities (Mesnage et al., 2008). 
 
3.1.4.2.1. Protocol optimization 
Our first attempts to detect PGH activities around the colonies on agar were inconclusive 
(data not shown). It was not possible to visualise a clear halo on E. faecalis plates. The halo 
was relatively small and the contrast was not good enough to take pictures. 
 
We hypothesized that the poor contrast of the halo could be due to two factors: (i) the 
relatively high cross-linking index of E. faecalis peptidoglycan as compared to M. luteus; 
(ii) the fact that autoclaved cells incorporated in the plates contain not only peptidoglycan, 
but lipids, proteins, carbohydrates and nucleic acids that cannot be digested by autolysins. To 
improve the sensitivity of the assay and to increase the contrast of the background in the 
plates, the experiment was repeated using an E. faecalis mutant with a less cross-linked PG (a 
more sensitive substrate for PGHs). This mutant (called D4) has four deletions in pbp genes 




Cell preparations of the D4 substrate were used to test the impact of two treatments: cell 
disruption using the French Press and cell disruption followed by ebullition in SDS and 
extensive washes in water (Fig. 34A). The comparison of plate assays using these two 
different substrates revealed that breaking cells without treating with SDS was not sufficient 
to detect clear halos (Fig. 34B). Cell disruption followed by SDS treatment clearly improved 
the sensitivity of the assay. We found that cell walls at a final concentration of OD600=1.5 
gave the best results as shown in (Fig. 34C). 
 
Figure 34. Detection of autolytic activities on agar plate containing broken E. faecalis cells. (A), 
Strategy followed to produce broken cell extracts or cell walls. (B), Plates containing various 
concentrations of broken cells (left: OD600=0.25; middle: OD600=0.5; right: OD600=1.5) gave a poor 
halo contrast. (C), plates containing broken cells treated with SDS (ie cell walls) at various 




3.1.4.2.2. Analysis of PGHs activities 
The same control strains as those described in section 3.1.4.1 were analysed using the 
optimized method. JH2-2, A-GFP and the two atlA mutants (∆A and atlAE212Q-gfp) showed a 
halo of a similar size (Fig. 35) indicating that AtlA does not significantly contribute to the 
surface activities digesting E. faecalis PG. The ∆BC mutant showed a very small halo 
indicating that the two enzymes AtlB and AtlC are the most active enzymes produced by E. 
faecalis able to digest this substrate. The triple ∆ABC mutant colonies showed no halo, 
indicating that AtlA, AtlB, and AtlC are the only PGHs that can be detected by this assay. 
The activity of spontaneous mutants from the three groups A, B and C previously described 
was analysed. A halo was identified around the colonies for all mutants except for two of 
them (Fig. 35). 
In group A, mutants 05 and 14 had a halo similar to the atlAE212Q-gfp parental cells (E212Q). 
Mutants 09 and 20 showed no activity, a phenotype similar to that of the ∆ABC mutant. This 
suggested that the very long chains formed by these two mutants could result from a mutation 
in atlB and atlC (Fig. 35). 
In group B, all mutants had a halo with a size similar to the parental strain atlAE212Q-gfp, with 
the exception of mutant 27 which displayed a slightly bigger halo at 24 hours and mutant 23 
which displayed a slightly smaller halo (Fig. 35A). The overexpression of a PGH digesting E. 
faecalis substrate could explain the suppression of the phenotype of the class A mutant. The 
lower expression of surface-exposed PGH activities in mutant 23 remains unexplained. 
In group C mutant 18 seemed to form a bigger halo than the parental strain. The increased 
enzymatic activity detected is in agreement with the smaller cell chains formed by mutant 18 
as compared to the parental atlAE212Q-gfp strain. 
 
Figure 35. Detection of cell surface PGH activities on agar plates containing E. faecalis cell walls 
after 24 hours (A) or 48 hours (B). Control strains (boxed) are described in (Fig. 33). 
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3.1.5. Identification of PGH hydrolytic profiles by zymogram analysis 
 
3.1.5.1. Detection of PGHs activities in control strains 
Our previous plate assays with M. luteus as a substrate indicated that none of the mutants 
displayed PGH activity against this heterologous substrate. To further analysis the PGH 
activities produced by spontaneous mutants, we carried out zymogram experiments using 
exclusively E. faecalis as a substrate. The principle of this method is to separate proteins 
under denaturing conditions on a SDS-PAGE containing purified cell wall as substrate. 
Proteins are then renatured in a buffer containing a non-ionic detergent (triton X-100) and the 
bands with hydrolytic activities are detected as a clearing zone in the gel. 
Two types of protein samples were tested (crude extracts and supernatants) using different 
pHs pH 5.0, 6.2, 7.4 and 8.5 and different incubation times to maximize the possibility to 
detect all PGHs produced by mutants. To increase the sensitivity of the assay, we used as a 
substrate, cell walls from the E. faecalis mutant with deletions in 4 genes encoding PBPs (∆4, 
see 3.1.4.2.1).  
Using bacterial crude extracts, wild type hydrolytic profiles revealed two clear bands with 
activity (Fig. 36A). The band with the highest molecular weight corresponds to AtlA activity 
because it can be seen in WT (lane 1) and strain ∆BC, but disappears in all atlA strains 
(atlAE212Q-gfp, lane 3; ∆A, lane 4 and ∆ABC, lane 6). As no AtlA activity could be detected in 
the producing the AtlA-GFP fusion, (lane 2) we concluded that the fusion is not active. The 
band with the lowest molecular weight corresponds to AtlB activity as it is present in the WT 
(lane 1), A-GFP (lane 2), atlAE212Q-gfp (lane 3) and ∆A (lane 4) strains, but it cannot be seen 
in all atlB crude extracts and supernatants: (strains ∆BC, lane 5 and ∆ABC, lane 6). AtlC 
could be identified in some cases as a band just below AtlB activity. As expected, AtlC 
activity was no systematically detected because it is masked by AtlB. 
Longer incubation (after 10 days) increased all bands intensity but no other band appeared 
except AtlB and AtlA. AtlA can be detected with all pHs (5.0, 6.2, 7.4 and 8.5), (Fig. 36B, C 
and D) AtlB could be detected with pH 5.0, 6.2 and 7.4 but poorly at pH 8.5 as previously 
described (Mesnage et al., 2008). 






Figure 36. Zymogram detection of PGH activities in control strains using crude extract samples 
and E. faecalis autoclaved cells as a substrate. The same buffer was used at different pHs: 5.0 in 
(A), 6.2 in (B), 7.4 in (C) or 8.5 in (D). For each buffer condition, a picture was taken after 1 day (left 







Figure 37. Zymogram detection of PGH activities in control strains using culture supernatants. 
The same buffer was used at different pHs: 5.0 in (A), 6.2 in (B), 7.4 in (C) or 8.5 in (D). For each 
buffer condition, a picture was taken after 1 day (left hand side gel) or 10 days (right hand side gel) of 










3.1.5.2. Detection of PGH activities in mutant strains 
The PGHs activities produced by the mutants were analysed by zymogram using E. faecalis 
∆4 cell walls as a substrate using crude extract (Fig. 38) and supernatants (Fig. 39), different 
pHs and incubation times. 
 
The same autolytic profile as the parental strain was detected in nearly all mutants (32/34). 
Generally, the only activity detected was AtlB and in some case AtlC (Fig. 38B) and there 
was no difference using different pHs or incubation time. 
This suggested that the formation of shorter chains was not associated with the production of 
a novel autolysin or an increase in AtlB activity. Only two mutants (9 and 20) showed no or 
less AtlB activity, respectively. This result is in agreement with the plate assay (Fig. 35) 
indicating that mutants 9 and 20 have no halo. 
Altogether, the zymogram data suggested that the long chains in mutants 9 and 20 (class A) 





Figure 38. Zymogram detection of PGH activities in mutant crude extracts. The same buffer was used at different pHs: 5.0 in (A), 6.2 in (B), 7.4 in (C) 






Figure 39. Zymogram detection of PGH activities in mutant culture supernatants. The same buffer was used at different pHs: 5.0 in (A), 6.2 in (B), 7.4 




3.1.6. rp-HPLC analysis of mutant peptidoglycan structure 
Zymogram did not reveal any change in the autolytic profile of most spontaneous mutants, so 
we hypothesized that it may not be the PGHs which are altered in the mutants, but the PG 
structure that is less digested by PGHs. To test this hypothesis, we analysed the PG structure 
of all mutants. PG was purified using established methods and digested with mutanolysin 
(Bouhss et al., 2002). PG soluble fragments (disaccharides-peptides) were separated by 
reversed phase HPLC as described in the materials and methods section. 
Overall, all mutants traces were virtually identical to that of the parental strain see Fig. 40 as 
an example. Only one trace appeared different (mutant 3), with a high proportion of 
muropeptides containing tripeptides stem (indicated with an arrow) (Fig. 41), however, a 
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Figure 40. rp-HPLC muropeptide comparison of the parental strain with a spontaneous 
mutant. The parental trace (black) is superimposed with that of mutant 99 to show the 
reproducibility of the muropeptide separation and illustrates the lack of significant differences 
between the two samples, a property that also applied to most samples analysed. 
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Figure 41. rp-HPLC analysis of PG muropeptide profiles of spontaneous mutants. All traces were 
virtually identical, except mutant 03 which revealed a higher abundance of disaccharide-tripeptide 




Figure 42. Biological replicate of the comparative muropeptide analysis of WT and mutant 03. 
Only one mutant had a muropeptide profile that seemed different from that of the parental strain 






3.1.7. Whole genome sequencing of spontaneous mutants 
The genomes of spontaneous mutants were sequenced to identify mutations responsible for 
the phenotype observed. The chromosomal DNA was extracted and its integrity was tested on 
agarose gel (Fig. 43A). Although samples were contaminated by RNA high molecular weight 
DNA was detected for all samples, confirming the integrity of the samples. All DNAs were 
completely digested using the HindIII restriction enzyme as judged by the disappearance of 
the high molecular weight DNA (Fig. 43B).  
 
 
43. Agarose gel electrophoresis of purified chromosomal DNA of spontaneous mutants. (A), One 













DNA libraries were prepared by Dr Paul Health at the Sheffield Institute for Translational 
Neuroscience (SITraN) and sequenced on an ILLUMINA HiSeq sequencer. Reads were 
assembled by Dr Roy Chaudhuri in the department of Molecular Biology and Biotechnology 
(MBB) against the JH2-2 draft genome available.  Dual indexed DNA samples were prepared 
using the Illumina Nextera XT DNA kit and run on a HiSeq 2500 sequencer in high output 
run. Sequence reads were adapter trimmed using Cutadapt  (Martin, 2011), and mapped to the 
reference genome using BWA-MEM (Li, 2013). SNPs were called using FreeBayes v0.9.20, 
run via Snippy 3.0 (https://github.com/tseemann/snippy) using default settings, which exclude 
reads with mapping quality below 60 and SNPs with less than 10-fold coverage. 
 
3.1.7.1. Genome analysis of class A mutants 
Two of the four group A mutants forming longer chains than the parental strain contained 
mutations that could account for their phenotype (mutants 5 and 9), whilst no mutations were 
identified in the two others (14 and 20) (table 5). Mutant 5 has a single base deletion in the 
open reading frame encoding an unknown protein (AdmA for AtlA display mutant A) that 
leads to a premature stop codo. The resulting protein has a truncation of 43 C-terminal amino 
acids. In collaboration with S. Kulakauskas (INRA, Jouy en Josas, France), we have shown 
that AdmA is required for the surface translocation of AtlA in E. faecalis and its orthologue 
AcmA in L. lactis (Fig. 44). Mutant 9 harbours an entire deletion of prophage pp1 (Matos et 
al., 2013)  that encodes AtlB. 
 
Figure 44. Zymogram analyses of L. lactis MG1363 and E. faecalis OG1RF. Crude extract and 
supernatants of L. lactis MG1363 (A) or E. faecalis OG1RF (B) and isogenic admA mutants were 
loaded on a 12% SDS-PAGE and activities were visualized after renaturation. Protein sizes in kDa are 
indicated on the left. Pre-proteins are indicated as black triangles, secreted proteins (after cleavage of 
the signal peptides) as white triangles, and proteolytically processed autolysins as grey triangles. 
Molecular weights in kDa are indicated on the left side of the gel. 
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3.1.7.2. Genome analysis of class B mutants 
Group B mutants isolated from mutant 14 correspond to suppressors of the very long chain 
phenotype. Mutations potentially responsible for the short chain phenotype were identified in 
9 out of the 10 group B mutants (table 5). 6 mutants had mutations in atlA including 
premature stop codons abolishing the production and/or surface display of AtlA (table 5). 
Two identical deletions of a single amino acid were found in secA. Finally, a single amino 
acid substitution was identified in a class B PBP (mutant 28). 
 
3.1.7.3. Genome analysis of class C mutants 
Group C mutants suppress the long chain phenotype due to the production of the inactive 
AtlAE212Q-GFP allele. Five out of 19 class C mutants did not reveal any difference with the 
reference genome. Six mutants had mutations in atlA, five of them being identical to the ones 
found in group B mutants. Three mutations were found in secA, including one not previously 
found in group B mutants. One mutation was found in secY and two others in genes encoding 
an ABC transporter and a protein involved in biotin transport (table 5). Mutations in secA and 
secY, were mapped on the crystal structure of the SecAEGY complex (Fig. 45). This was 
achieved by aligning the E. faecalis sequences with the sequences corresponding to the 
sequences of the secAEGY components used to generate the 3D structure available in the 












Figure 45. Mapping of E. faecalis secA and secY mutations on the crystal structure of the 
complex of Aquifex aeolicus SecYEG and B. subtilis SecA in its closed form (PDB 3DL8). (A) is a 
bottom view, showing the SecY channel (c) and (B) is a side view.  The different domains are colored 
are as follows: bright blue, SecE; magenta, SecG, purple, NBD1 (nucleotide binding domain 1); blue, 
NBD2; yellow, helical scaffold domain (HSD); red, 2 HFD (Helix Finger Domain); orange, HWD 
(Helical Wing Domain); grey, “joint” region connecting SD and NBD2; bright green, pre-protein 
binding domain (PBD); light green, SecY. The mutations SecA R548H, SecA D377 and SecY L337S 
seem to group around the region where the HSD (yellow) meets the PDB (bright Green), at the 




Coverage Mutation WT Mut Read Nb NT position Locus (gene name) Function
5 41.2 del ATT AT AT:32 ATT:1 416/519 Frameshift L139 → stop Truncation of 43 C-ter AA JH2-2_0604 (admA ) Unknown
9 70.6 Prophage excision (encodes atlB ) 49,104 bp deletion JH2-2_1253-1327 (pp1 ) Septum cleavage
14 67.4 NO SNP detected
20 42.0 NO SNP detected
29 65.2 SNP C T T:57 C:0 169/2937 Premature stop Q57 → stop Stop 4 AA after signal peptide JH2-2_0632 (atlA ) Septum cleavage
24 62.9 SNP C A A:108 C:0 696/2937 Premature stop Y232 → stop Stop 50 AA after start of catalytic domain JH2-2_0632 (atlA ) Septum cleavage
22 27.5 SNP C T T:43 C:0 1057/2937 Premature stop Q353 → stop Stop 5 AA before the 1st LysM JH2-2_0632 (atlA ) Septum cleavage
27 44.0 SNP C A A:53 C:1 1508/2937 Premature stop S503 → stop Stop 10 AA after the start of the 3rd LysM JH2-2_0632 (atlA ) Septum cleavage
26 58.8 SNP C A A:66 C:0 1682/2937 Premature stop S561 → stop Stop 1 AA after the start of the 4th LysM JH2-2_0632 (atlA ) Septum cleavage
21 71.2 SNP C A A:59 C:0 2194/2937 AA substitution Q732 → K Subtitution 5 AA before the stop codon JH2-2_0632 (atlA ) Septum cleavage
23 35.8 Del TCT TCT tct TCT TCT TCT:23 TCT tct:0 1130/2538 Inframe deletion   E377 deletion Nucleotide binding domain 1 JH2-2_1593 (secA ) Protein secretion
25 45.7 Del TCT TCT tct TCT TCT TCT:29 TCT tct:0 1130/2538 Inframe deletion   E377 deletion Nucleotide binding domain 1 JH2-2_1593 (secA ) Protein secretion
28 47.7 SNP G T T:71 G:0 1651/2229 AA substitution A551 → S Transpeptidase domain JH2-2_0810 (pbpC ) PG polymerisation
30 69.4 NO SNP detected
1 22.8 SNP C T T:14 C:0 169/2937 Premature stop Q57 → stop Stop 4 AA after signal peptide JH2-2_0632 (atlA ) Septum cleavage
8 51.2 SNP C T T:58 C:0 169/2937 Premature stop Q57 → stop Stop 4 AA after signal peptide JH2-2_0632 (atlA ) Septum cleavage
19 42.6 SNP C A A:87 C:0 696/2937 Premature stop Y232 → stop Stop 50 AA after start of catalytic domain JH2-2_0632 (atlA ) Septum cleavage
17 40.5 SNP C T T:60 C:0 1057/2937 Premature stop Q353 → stop Stop 5 AA before the 1st LysM JH2-2_0632 (atlA ) Septum cleavage
6 18.3 Del/Ins AGATT CAATC CAATC:10 AGATT:0 1814/2937 AA substitution K604 → T Subtitution 6 AA before theend of the 4th LysM JH2-2_0632 (atlA ) Septum cleavage
16 54.7 SNP C A A:55 C:0 2194/2937 AA substitution Q732 → K Subtitution 5 AA before the stop codon JH2-2_0632 (atlA ) Septum cleavage
98 30.6 SNP C T T:41 C:0 209/2538 AA substitution R70 → H Nucleotide binding domain 1 JH2-2_1593 (secA ) Protein secretion
11 47.0 SNP C T T:41 C:0 209/2538 AA substitution R70 → H Nucleotide binding domain 1 JH2-2_1593 (secA ) Protein secretion
2 31.6 Del TCT TCT tct TCT TCT TCT:24 TCT tct:0 1130/2538 Inframe deletion   E377 deletion Nucleotide binding domain 1 JH2-2_1593 (secA ) Protein secretion
18 100.9 Del TCT TCT tct TCT TCT TCT:53 TCT tct:0 1130/2538 Inframe deletion   E377 deletion Nucleotide binding domain 1 JH2-2_1593 (secA ) Protein secretion
4 46.1 SNP C T T:35 C:0 1643/2538 AA substitution R548 → H Joint region connecting NBD1 and NBD2 JH2-2_1593 (secA ) Protein secretion
0 36.8 SNP T C C:54 T:0 1010/1299 AA substitution L337 → S Entry of the SecY channel JH2-2_0233 (secY ) Protein secretion
3 61.4 SNP G A A:48 G:0 1043/1569 AA substitution G348 → D ? JH2-2_0191 ABC transporter
99 20.3 SNP G T T:17 G:0 218/549 AA substitution G73 → V ? JH2-2_2551 Biotin transport?
7 12.3 NO SNP detected
10 37.9 NO SNP detected
12 44.1 NO SNP detected
13 61.7 NO SNP detected





















In this chapter, we identified and characterised 34 spontaneous mutants with altered septum 
cleavage based on a phenotypic screen of bacterial colony morphologies in semi-solid agar 
(Fig. 30). These included mutants forming chains longer or shorter than the parental strain. 
Putative mutations responsible for the cell separation changes were identified by whole 
genome sequencing. 
 
Despite the clear phenotype difference between the colony morphology of the wild-type strain 
JH2-2 and the atlA derivative, we could not isolate any spontaneous mutants forming long 
chains from JH2-2. The fact that the atlA mutant is able to grow in the medium used for the 
screen suggests that mutants may have arisen, but we did not detect them in the fast growing 
“comets” formed by the parental cells. It would be interesting to explore other experimental 
conditions to re-do this experiment. For example, use lower concentrations of agar to 
exacerbate the phenotype difference between wild-type and chain forming mutants. Other 
conditions such as temperature or low osmolarity conditions to favour the emergence of 
mutants with a PG structure more resistant to mechanical stresses. Another possibility would 
be to repeat these experiments starting with a DatlBDatlC parental strain to isolate chain 
forming mutants. AtlB and AtlC have been shown to have a low septum cleavage activity so 
their absence could help to identify other genes involved in this process.  
 
Using a strain deficient for AtlA activity (JH2-2 atlAE212Q-gfp), we were able to identify 
several mutants forming longer chains (group A) or shorter chains (group C). We also 
identified mutants suppressing the extreme chaining phenotype of group A mutants. 
(group B). For 8 out of 34 mutants, we did not identify any mutation that was likely to be 
responsible for the change in the cell chain length. 
Mutations associated with a septum cleavage defect  
4 spontaneous mutants forming cell chains longer than the parental strains were isolated. 
Whole genome sequencing of 2 of them revealed mutations that could be responsible for this 
phenotype. Mutant 5 had a nonsense mutation in an unknown gene that we named admA. This 
gene was also identified in our transposon mutagenesis. Although AdmA does not show any 
similarity with sequences from the protein databases, structure predictions suggest that it is 
related to polysaccharide deacetylases see (Fig. 54). 
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Interestingly, the admA mutation does not alter AtlA activity but reduces AtlA surface 
localisation. The predicted cytoplasmic localisation of AdmA makes it unlikely to function as 
a peptidoglycan deacetylase, but it could potentially be involved in the modification of Epa. 
Surface polysaccharides are polymerised in the cytoplasm and then translocated onto the cell 
surface  (Mistou et al., 2016). It is therefore possible that AdmA modifies the Epa polymer 
that contains glucosamine. The impact of Epa deacetylation on AtlA translocation remains 
difficult to explain. An alternative possibility is that the structure predictions are misleading 
and that AdmA does not display any GlcNAc deacetylase activity. It is worth pointing out that 
the sequence predictions presented in (Fig. 55) introduce several long gaps in AdmA. 
Determining the crystal structure of AdmA will provide insights into its function.  
The second mutation identified corresponds to a complete excision of prophage 1 encoding 
AtlB. This explains why AtlB activity cannot be detected in zymogram using protein crude 
extracts from mutant 9 (Fig. 38). Previous studies have shown that AtlB can cleave the 
septum in the absence of AtlA (Mesnage et al., 2008), therefore explaining the long chain 
phenotype of mutant 9. 
Mutation associated with an increased septum cleavage activity  
Most mutations associated with increased septum cleavage abolish the production or surface 
display of the AtlAE212Q-GFP protein. Several mutations introduce a premature stop codon 
that prevent the production of a catalytically active AtlA or lead to the truncation of at least 2 
LysM modules. Previous work indicated that removal of the LysM domain drastically reduces 
the activity of AtlA (Eckert et al., 2006). Although it has a less pronounced impact, truncation 
of 2 LysM modules or more also reduces the binding to PG significantly (B. Salamaga and S. 
Mesnage, unpublished). Two mutations associated with shorter chains (K604T and Q732K) 
The impact of these mutations remains to be established, but we can hypothesize that they 
lead to a lower binding affinity to PG. Altogether, the mutations in AtlA associated with 
increased septum cleavage suggest that the absence of this protein at the cell surface allows 
other PG hydrolases to access the septum to cleave it. The enzymes involved include AtlB, 
AtlC and other(s) that remain to be identified (Mesnage et al., 2008). Interestingly, this result 
is in agreement with unpublished data indicating that the atlA deletion mutant forms cell 
chains shorter than the strain producing the AtlAE212Q-GFP inactive enzyme (B. Salamaga and 
S. Mesnage, unpublished). 
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To confirm that the presence of AtlAE212Q-GFP prevents other PG hydrolase from cleaving the 
septum, several experiments could be considered. 
We will have to complement the atlA mutations described in (table 5) with the atlAE212Q-gfp 
allele to show that this leads to an increased size of the cell chains. Using the 
complementation vector based on the tetracycline-inducible promoter recently built in the lab 
will allow complementing the mutations with increasing amounts of AtlAE212Q-GFP. A similar 
complementation experiment could be carried out with the same inducible system to express 
the LysM domain alone to test if the saturation of PG glycan chains with this domain prevents 
other enzymes from cleaving the septum. 
 
We identified 3 mutations in secA and one in secY in the mutants forming cell chains shorter 
than the parental strain. This may reflect the fact that AtlA is secreted via the general 
secretory pathway rather than a specific transporter which has been described for other 
autolysins (Lenz et al., 2003). This result is somewhat surprising since it has been proposed 
that the secretion machinery in E. faecalis forms a so-called exportal that is not localised at 
the septum (Kline et al., 2009). The mutation identified in secA, and secY have not been 
reported previously and their impact on the secretion of surface proteins awaits further 
analysis. Using proteomics, we could compare the proteins in culture supernatants and cell 
surface extracts from wild-type and sec mutants. Before doing these rather complex and 
costly experiments, we could use the inducible expression system that we will construct to 
complement mutations in atlA, (see previous paragraph), to compare the secretion rate of 
AtlA tagged with 6 C-terminal His  residues in both the parental and sec mutants. A key 
question will be to figure out if the sec alleles in the mutants forming shorter cell chain length 
affect the secretion of AtlA and/or other proteins. 
 
One mutation was found in a gene encoding a class B PBP that has not been studied to date. 
Although the mutation is not in the predicted active site, it could be associated with a slight 
decrease in PG crosslinking (Fig. 42). This result is extremely interesting as it suggests that 
PBPs play specific roles in E. faecalis PG polymerisation. Again, this mutation will have to 
be complemented to confirm the role of PbpC in septum cleavage. It is worth noting that a 
previous screen to isolate transposon mutants suppressing the chain forming of L. lactis 
AcmA identified several insertions in the gene encoding PonA, a class A Pbp (Mercier et al., 
2002). 
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Spontaneous mutants with no detectable genetic difference 
The overall sequence coverage was satisfactory for all the genomes that did not reveal any 
obvious mutation between (30x-70x) for most genome. Only mutants 6 and 7 had relatively 
low coverage (18.3 and 12.3) respectively. It is therefore tempting to assume that a re-
sequencing of these samples would not identify any mutation. It must be pointed out that the 
algorithm that was used to identify mutations is primarily designed to identify single 
nucleotide polymorphism (SNPs), short deletions and/or insertions (such as in mutants 5, 23 
or 26). Genome re-arrangements or larger deletions were not detected in the original analysis. 
For example, the 49.1 kbp deletion in mutant 9 was identified by “manual inspection” of the 
whole genome assembly. A careful and systematic analysis of small deletions, re-
arrangements, or gene duplications is therefore required. Alternatively, other sequencing 
strategies such as PacBio sequencing involving much longer reads (>30kpb versus 150bp) 
could solve this problem. However, this is a relatively costly option (approx. £1.5k/genome 
for PacBio sequencing versus £60/genome using Illumina sequencing). Finally, another 
possibility could be that these ‘‘mutants’’ are not mutants and therefore have a genome 
identical to the parental strain. Bearing in mind the sedimentation profiles shown in Fig. 32 it 
is likely that clones 10, 12, 13, 14, 15 and 30 are not true mutants as they are indistinguishable 
from the parental strains. 
In parallel to the analysis of the genomic data available, several experiments could be carried 
out to understand why these mutants have an altered septum cleavage activity leading to the 
formation of extremely long (mutants 14 and 20) or short relatively short chains (mutants 30, 
7, 10,12, 13 , 15). 
- Do the mutations affect AtlAE212Q-GFP expression levels?  
Several mutants with mutations abolishing the production of AtlAE212Q-GFP display an 
increased septum cleavage activity (Table 5). We could therefore quantify the expression 
level of AtlAE212Q-GFP using flow cytometry or western blot analyses using in-gel 
fluorescence to quantify the GFP in cell extracts. 
- Do the mutations affect the localisation of atlAE212Q-gfp? 
We could test the presence of AtlAE212Q-GFP at the cell surface by immunofluorescence using 
anti-AtlA or anti-GFP antibodies. In parallel, deconvolution fluorescence microscopy could 




- Do the mutations alter the cell wall composition and susceptibility to septum-cleavage enzymes? 
Although we did not identify any novel autolytic activity in protein extracts from the mutants 
with no detectable SNPs, we have not explored if their cell wall is more susceptible to septum 
cleavage activities. To test this possibility, we could use autoclaved cells corresponding to 
these mutants to do zymograms with wild-type extracts. 
Alternatively, we could use these mutants as substrates to measure the septum cleavage 
activity by flow cytometry (Mesnage et al., 2008) again using wild-type protein extracts. 
 
 
3.2. Isolation of transposon mutants impaired in AtlA activity 
3.2.1. Construction of the transposon mutant library 
3.2.1.1. pZXL5 as a transposon delivery system 
The Mariner system has been selected. In this system, the transposon jumps into TA 
dinucleotides in the chromosome (Munoz-Lopez and Garcia-Perez, 2010).  Because E. 
faecalis genome is AT-rich, the Mariner transposon system is able to generate a large variety 
of insertions, and is therefore considered as "random". The screening for the transposon 
mutants was performed on an agar plate containing M. luteus to detect of AtlA activity as a 
halo around the colonies. Once the mutants that did not have a halo around the clones on M. 
luteus plates were isolated, interrupted genes were identified by reverse PCR. The transposon 
system we used was recently described for E. faecium (Zhang et al., 2012a). 
Plasmid pZXL5 used for the mutagenesis is described in (Fig. 46). This plasmid has a size of 
11760 bp and contains the following elements: 
- An origin of replication in Gram negative bacteria (Ori), for cloning purposes in 
E.coli;  
- A thermosensitive origin of replication in Gram-positive bacteria (Orits), which 
will be only functional at 28℃; 
- A gene conferring resistance to chloramphenicol (CmR) in both Gram-positive and 
Gram-negative bacteria. 
- A Mariner transposon cassette made of a gentamycin resistance gene flanked by two 
inverted repeats (IR);  
- A transposase gene under the control of a nisin- inducible promoter; 
- A nisin-responsive two-component system (NisRK) that will allow the expression of 




Figure 46. Plasmid map of pZXL5 used for transposon mutagenesis. The plasmid contains (i) an 
origin of replication in Gram negative bacteria (Ori) for cloning purposes in E. coli; (ii) a 
thermosensitive origin of replication in Gram-positive bacteria Ori
ts
), which is non-functional at 42℃; 
(iii) a gene conferring resistance to chloramphenicol (Cm
R
) in both Gram-positive and Gram-negative 
bacteria; (iv) a Mariner transposon cassette made of a gentamycin resistance gene (Gm
R
) flanked by 
two inverted repeats (IR); (v) a transposase gene under the control of a nisin- inducible promoter; (vi) 
a nisin-responsive two-component system (NisRK) that will allow the expression of the transposase 




3.2.1.2. Construction of the Transposon library 
The transposon library was built using plasmid pZXL5 described above in four sequential 
steps (Fig. 47). 
STEP 1: selection of transformants harbouring pZXL5. pZXL5 was introduced into E. 
faecalis OG1RF by electroporation. Transformants harbouring pZXL5 were selected on BHI 
agar plates containing 128 mg/mL gentamycin (Gm128) and 10 mg/mL chloramphenicol 
(Cm10) at a permissive temperature to allow plasmid replication (28℃). The presence of the 
plasmid was checked by antibiogram (using antimicrobial discs) and PCR using pZXL5 
specific primers  to check the presence of the plasmid in the transformed cells. 
STEP 2: amplification of the population of pZXL5 transformants. A transformant was 
grown overnight in 200 mL BHI broth containing Gm128 and Cm10 at 28℃ to amplify the 
population of pZXL5 transformants. 
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STEP 3: induction of transposition with nisin. Transposition was induced by inoculating 
200µl of the overnight culture in 200mL of BHI broth containing Gm128 supplemented with 
nisin (25ng/mL). This culture was incubated overnight at 42℃. At this temperature, the 
plasmid cannot replicate and GmR colonies are in theory resulting from a transposition event 
onto the chromosome. 
STEP 4: amplification the transposons library. The nisin-induced culture containing 
transposon mutants was used to inoculate BHI broth (200µl in 200mL) containing Gm128 and 
incubated at 42℃ to amplify the population of mutants. 
 
 
Figure 47. Steps followed to construct the transposon library. See paragraph 3.2.1.2. For a 
detailed description of the protocol used. 
 
3.2.1.3. Analysis of the Library 
The transposon library was analysed to estimate the efficiency of transposition. Mutants were 
grown in BHI agar containing gentamycin (Gm128) or chloramphenicol (Cm10) to estimate the 
number of colonies resulting from a transposition event (Fig. 48). Growth at 42℃ should in 
theory eliminate the plasmid, which is thermosensitive. Cells growing at 42℃ in the presence 
of chloramphenicol can result from an insertion of the whole plasmid on the chromosome or 
from a mutation on the plasmid allowing its replication at a non-permissive temperature. By 
comparing the number of CFUs on gentamycin and chloramphenicol plates, we determined 
that less than 5% of the GmR colonies were resistant to chloramphenicol. This indicated that 







Figure 48. Analysis of the elimination of the plasmid in the mutant library. (A), Serial dilution of 
the library were plated on selected media containing gentamycin (Gm128) chloramphenicol (Cm10) (B) 
and grown at 42°C. Comparison of CFU numbers between condition A and B indicate that more than 
95% cells lost the plasmid. 
 
 
3.2.2. Identification of atlA deficient mutants 
The dilution of the library before plating was optimized to visualise the AtlA activity around 
individual colonies. Transposon mutants were plated on BHI agar plates containing Gm128   
M. luteus PG as a substrate to detect AtlA activity as a halo around the colonies. We 
determined that approximately 200-300 colonies per plate were an optimal density to analyse 
halos around colonies. This corresponds to plating 100µl of a 10-3 dilution of the library 
Plastic Petri Dishes (100 mm x 15 mm) (Fig. 49). 
 
Figure 49. Optimisation of dilution factor to be used to plate the library on selective media. 
100µl of a 10-3 dilution of the library was found to give the most suitable colony density to 
visualise AtlA activity. 
 
Three series of screens were performed, each corresponding to approximately a hundred 
plates containing 200-300 colonies per plate. Altogether, we screened an estimated number of 
60,000 transposon mutants. We finally isolated 106 mutants including 3 clones with a bigger 
halo than the parental strain. An example of a screening plate is shown in Fig. 50. 
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Figure 50. Screening of transposons mutants on agar plate containing M. luteus). atlA mutants 
showing no halo around the colony are circled in red. 
 
 
3.2.3. Mapping of the transposon insertions sites 
3.2.3.1. Identification of mutants with an insertion in the atlA gene 
To find out whether the transposon inactivated atlA, we used two primers (AtlA_FW and 
AtlA_REV) flanking the atlA gene (Fig. 51A). In the absence of the transposon in the atlA 
gene, the expected size of the PCR product is 3kb. In contrast, if the transposition event has 
occurred in the atlA gene, the estimated amplification size is 5kb (Fig. 51B). To identify the 
site of insertion in atlA, we used a primer on the transposon (T7) and one in the atlA gene 
(AtlA_FW) (Fig. 51A). The PCR products (Fig. 51C) were sequenced. 
AtlA_FW
+ AtlA_REV

















Figure 51. Identification of mutants with a transposon insertion in atlA. (A), schematic diagram of 
a mutant with a transposon insertion in atlA. (B), Amplification of atlA gene containing a transposon 
insertion (lanes 1 and 2) or no insertion in atlA (lane 3). (C), analysis of the same clones as in (B) with 
oligonucleotides AtlA_FW and T7. Only clones in lanes 1 and 2 have a transposon inserted in atlA and 




The nucleotide sequences of the PCR products were aligned with the sequence of the inverted 
repeat of the transposon to identify the first base corresponding to the insertion site in the atlA 
(Fig. 52A). The sequence starting after the last IR nucleotide aligned with the atlA sequence 
to identify the exact position of the insertion (Fig. 52B). All the insertions that have been 
identified in atlA are summarized in (Fig. 52C). The insertion site of 23 additional atlA 
transposon mutants was not identified. 



















Figure 52. Identification transposition sites in atlA. Nucleotide sequences of the PCR products 
amplified with oligos T7 and AtlA_FW were aligned with the inverted repeat sequence of the 
transposon to identify the first base corresponding to the insertion site. (A), Alignment of the 
sequences starting after the inverted repeat sequences were aligned to the atlA sequence to identify 
precisely the insertion site. (B), Alignment of the sequences starting after the IR with the atlA ORF. 
The plain arrows indicate sequences identical to the atlA reference gene. (C), Summary of the 
transposon insertion sites mapped in the atlA gene. 23 other atlA mutants were not mapped. 
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3.2.3.2. Identification of insertion sites on the E. faecalis chromosome 
Transposition sites on the chromosome have been mapped using a reverse PCR strategy 
described in (Fig. 53A). The chromosomal DNA was extracted from each mutant. Purified 
DNA was diluted to 4ng/µl and digested with SspI restriction endonuclease (New England 
Biolabs) which cleaves in the gentamycin resistance cassette and frequently in the 
chromosome (the genome contains 3600 SspI restriction sites). 
Digested products were diluted to a concentration of 1ng/µl and self-ligated with T4 DNA 
ligase. PCR was carried out on 5µl of the ligation products using two divergent primers on the 
transposon (Mar_up, and Mar_dn). PCR products were gel extracted and sent for sequencing 
using the primer T7. 
An example of PCR products is shown in (Fig. 53B). The genes that have been interrupted by 
a transposon insertion were identified using E. faecalis V583 genome as a reference sequence 
and using the blast software (http://blast.ncbi.nlm.nih.gov/Blast.cgi). 



















Figure 53. Strategy used to map the transposition sites by reverse PCR. (A), Chromosomal DNA 
was extracted, digested with SspI, self-ligated, used for a reverse PCR with oligos Mar_up, and 
Mar_dn. PCR products as shown in (B) were sent for sequencing with oligo T7. Molecular weights in 
kbp are indicated on the left side of the gel. 
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Site of Insertion 
(nt) Mutant ID Gene 
EF_10017 EF_0018 
700 32 sigma-54 factor interaction 
domain-containing protein 1239 94 
EF_10019 EF_0020 809 13, 108 & 109 b PTS system mannose-specific transporter subunit IIAB 
EF_10506 EF_0773 195 
3, 4, 19, 27, 37, 39, 41, 42, 43, 44, 
45, 46, 48, 49, 50, 51,53, 55, 56, 
58, 59, 60, 69, 71,72,73, 75,77,78, 
80, 81, 82, 84, 92, 93, 96, 98, 
100,101, 101, 105, 106 and 107 
admA 
EF_10533 EF_0799 







728 14, 40, 66,  
861 11, 57 
980 47, 64,  
985 30 
1249 76 
1290 8, 22, 26, 29, 34, 36, 38,  
1292 31, 35,  
1963 12 
NI 
21,33, 34, 35, 36, 38, 40, 47, 52, 
64, 66,70, 74, 79, 83, 85, 90, 95, 
97, 99, 103 & 104 
EF_10679 EF_0954 
325 18 Sugar-binding transcriptional 
regulator, LacI family  508 17 
EF_12044 EF_2674 677 16 Oligoendopeptidase F 
EF_12423 EF_3156 104 20 GntR transcriptional regulator 
NI NI NI 63,65,86,87,89,91 No PCR product 
NI NI NI 15, 28, 61, 62, 68, 88 No sequence data 
 
Table 6. Description all transposon mutants identified. NI: Not identified. 
a  Gene ID relates to the annotated E. faecalis V583 genome, the corresponding OG1RF gene names 
are also labelled  







Transposon insertions in seven different loci were identified: 
• EF_0018 encodes a 962 amino acid protein annotated as a sigma-54 factor interaction 
domain-containing protein. EF_0018 (MptR) is a putative σ54 (rpoN)-associated activator 
(Hechard et al., 2001). It has been shown that EF_0018 is required for sensitivity to 
mesenterin Y105, a class IIa pore-forming bacteriocin (Abee et al., 1995) but the mechanism 
of this resistance is unknown. Transposon insertion in EF_0018 is associated with a lack of 
AtlA activity. 
• EF_0020 encodes a 331 amino acid protein corresponding to the subunit IIA from a 
phosphotransferase system (PTS) specific for mannose. This gene is located downstream of 
EF_0018 and has been proposed to be under the transcriptional control of EF_0018. 
Interestingly, the transposon insertion in EF_0020 leads to an increased AtlA activity. Given 
that EF_0018 inactivation is associated with a decrease in AtlA activity, this suggests that 
EF_0018 is a repressing the expression of EF_0020. 
• EF_0773 (admA) encodes a 172 residues protein containing no obvious homology to any 
known domain in the Pfam database. AdmA contains a putative membrane anchor consisting 
of 22 hydrophobic amino acids predicted by the TMHMM server (Fig. 54).  
 
 
MFVFIAGMVG VIVGALIVTA SAALHSSYKE RKEVRYRELE HLVKEIESLN LLNKKVKEIL  60 
QKRELYIDRS IEYLSMDDCF ISIDDFIYLE SFSAQNNFYL PTYLIEEFFK KIAHRKVILT 120 
ASEVAEMGGH TYKGGRVILE NFSDEILAIIEDKKRKMQRL SNEPLHYFKA IK          172 
Figure 54. Topology prediction of AdmA protein. The TMHMM Server v. 2.0 
(http://www.cbs.dtu.dk/services/TMHMM/) was used to predict transmembrane helices which appear 
in red in the diagram shown above. 
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Although there is a canonical signal peptidase cleavage site after residue 22 (ASA↓A), the 
lack of a charged tail suggests that AdmA is not a secreted protein, but instead a cytoplasmic 
protein anchored on the membrane. AdmA homologs are found in E. faecalis, E. gallinarum, 
E. italicus, E. faecium, E. casseliflavus and other bacteria of the genus Enterococcus (identity 
ranging between 98 and 31%), in lactic bacteria such as L. lactis and in L. garviae (identity 
ranging between 84 and 82%) and in Melissococcus plutonius and Tetragenococcus 
halophilus. All strains carrying AdmA homolog thus belong to the Enterococcaceae family. 
A structural homology was detected between AdmA and a polysaccharide deacetylase of 
Streptomyces coelicolor using the Phyre server (Fig. 55). This server is predicting secondqry 
structures and matches them to a database of existing structures. Based on the similarities, a 





Figure 55. Structure prediction of the AdmA protein. The Phyre2 Server 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/) was used to predict the 3D structure of AdmA 
based on secondary structure homologies with proteins in the PDB database. (A), Structure 
prediction and secondary structures of residues 5 to 24 of AdmA compared to the 
transmembrane domain of cytochrome b6. (B), structure prediction of residues 39-168 and 
comparison with the secondary structure of E. coli β-1,6 N-acetylglucosaminidase. 
 
 100 
• EF_0954 encodes a 337 residues protein with homology to a transcriptional regulator 
from the LacI family  (Le Breton et al., 2005). This gene is located downstream of a putative 
operon involved in the metabolism of galactose, a carbohydrate present in E. faecalis cell 
wall-associated polymers (Hancock and Gilmore, 2002). 
• EF_2674 encodes a 604 amino acid-long protein homologous to oligoendopeptidases 
from L. lactis (Nardi et al., 1997). This gene is located upstream of a set of genes with 
unknown functions and downstream of genes involved in competence. The impact of the 
transposon insertion in EF_2674 on AtlA activity remains unclear. 
• EF_3156 encodes a 238 amino acid-long protein with homology to transcription factors 
belonging to the GntR family. EF_3156 has a DNA-binding helix-turn-helix domain at its N-
terminus and an effector-binding or oligomerisation domain at the C-terminus. EF3156 is 
located in a region of the chromosome containing genes related to carbohydrate metabolism. 
It is therefore tempting to assume that this gene controls the expression of genes involved in 
the production of surface polysaccharides which have been shown to modulate the activity of 
PG hydrolases (Emirian et al., 2009). 
 
3.2.4. Discussion 
In this chapter, we report the construction and screening of transposon libraries to identify 
mutants with reduced or abolished AtlA surface activity on agar plates. Unlike the 
mutagenesis described in chapter 3.1., the parental strain used here had a wild-type AtlA 
activity. Several mutants distinct from the ones previously described were identified.  
pZXL5 as a transposon mutagenesis system in E. faecalis  
The transposon mutagenesis system we used was originally described in E. faecium (Zhang et 
al., 2012a). This work showed that it also works in E. faecalis. However, our preliminary 
attempts using JH2-2 as a recipient strain suggested that the transposition efficiency in this 
strain is relatively low since a large proportion of gentamycin resistant clones (>30%) was 
also resistant to chloramphenicol, indicating that the whole plasmid was integrated on the 
chromosome. As we finished our first mutagenesis attempt in JH2-2, we had some feedback 
from colleagues who also tried unsuccessfully to construct a library in the same genetic 




We therefore decided to use E. faecalis OG1RF instead. To limit the isolation of identical 
mutants resulting from clonal expansion, we built three independent libraries that were 
successively screened to identify AtlA-deficient mutants numbered from 1 to 106. The admA 
transposon mutant was largely overrepresented and isolated more than 40 times (across all 
three libraries). Given the multitude and variety of mutations isolated in atlA, it is tempting to 
think that finding the same mutant over and over was more reflecting its key role in the 
control of AtlA activity rather than a low quality library. It could also indicate a better fitness. 
 
AtlA is essential for M. luteus hydrolysis  
Most of the mutants (14 out of 22) had insertions in the gene encoding atlA. This probably 
reflects the fact that abolishing the production of AtlA gives a complete lack of halo around 
colonies, which is easier to detect on the plates. In agreement with this hypothesis, virtually 
all the atlA insertion mutants are located in the first half of the gene where a gene interruption 
is likely to completely abolish the enzymatic activity. Although insertion of the transposon 
towards the end of the gene (after the second LysM module) could potentially reduce the 
activity of AtlA, none of these events were identified. The gene encoding AtlA is also 
relatively large (2.3 kbp), hence increasing the probability of transposon insertions in it. 
AtlA-deficient mutants harbouring a transposon insertion in admA (EF_0773 in V583) were 
identified. This confirmed our previous results from the screen of spontaneous mutants that 
led to the isolation of an admA mutant forming longer chains than the parental strain (table 6).  
Transcriptional control of carbohydrate metabolism modulate AtlA activity 
Three genes required for AtlA activity were related to sugar metabolism indicating that 
carbohydrate metabolism modulates AtlA activity or expression. Two genes (EF_0018 and 
EF_0954) are transcriptional regulators whilst the third (EF_0020) encodes a sugar 
transporter. EF_0018 is a σ54-interacting transcription factor that was shown to control the 
expression of EF_0020 in E. faecalis (Hechard et al., 2001). Mutations in E. faecalis, σ54 were 
isolated in a screen to identify mutants with enhanced biofilm formation (Iyer and Hancock, 
2012) and were associated with an altered biofilm composition. In particular, biofilms in σ54 
mutants had a reduced content of extracellular DNA resulting from AtlA-mediated autolysis, 
clearly linking this transcriptional regulation network to AtlA activity (Fig. 56). The 









Figure 56. Proposed regulatory network modulating the activity of AtlA. E. faecalis σ54 is a 
master regulator of sugar metabolism. It negatively controls AtlA-mediated autolysis via EF_0018, 
which controls EF_0020 expression (Hechard et al., 2001). The direct contribution of EF_0954 to 
EF_0020 transcriptional control is hypothetical. Black lines indicate transcriptional control, red lines 
post-transcriptional control. 
 
Previous work indicated that in Lactobacillus plantarum, the σ54-controlled mannose PTS 
system homologous to EF_0020 was capable of transporting glucose (Stevens et al., 2010). In 
E. faecalis, two surface polysaccharides, the capsule and Epa contain glucose and sugars 
derived from glucose (Hancock and Gilmore, 2002). Since OG1RF does not produce any 
capsule (Thurlow et al., 2009). One can assume that Epa composition is modulating AtlA 
activity. Further analyses are required to formally confirm this hypothesis. The identification 
of genes involved in sugar metabolism is in agreement with previous studies indicating that 
surface carbohydrates inhibit the enzymatic activity of AtlA in vitro (Emirian et al., 2009). 
The mechanism by which Epa inhibits AtlA activity is unknown, but by analogy with the 
work published in S. aureus, it is tempting to assume that steric hindrance prevents the 
binding of AtlA to its substrate (Schlag et al., 2010) at this stage, we do not know if the 
mutations identified have an impact on Epa structure, composition or abundance. Further 
experiments are also required to test if they alter AtlA binding to PG or AtlA enzymatic 
activity (or both). 
Two genes encoding an oligoendopeptidase and a transcriptional regulator potentially regulate 
AtlA activity 
Without further experiments, it is difficult to explain how the transposon insertions in the 
genes encoding an oligoendopeptidase and a transcriptional regulator from the Gntr family 
negatively control AtlA activity. Both genes are not part of operons so it is unlikely that the 
transposon insertion is causing any polar effect.  It is possible that the peptidase plays a role in 
the cleavage of peptide stems in muropeptides to facilitate their recycling. The target of the 
Gntr regulator remains to be identified. 
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3.3. Functional analysis of the genes potentially modulating septum cleavage 
 
3.3.1. In-frame deletion of the genes identified by transposon mutagenesis 
To confirm that the genes identified are responsible for the chain forming phenotype 
observed, we chose a selection of genes to build in-frame deletion mutants. An admA mutant 
had already been built by S. Kulakauskas (INRA, Jouy en Josas, France) and was shown to 
have the same long-chain forming phenotype. 
We focused on 3 other genes with a potential role in polysaccharide biosynthesis: EF0018 and 
EF0954, identified in our screen and EF0782 (rpoN) encoding σ54 and potentially required for 
the activity of EF_0018 and EF_0954. EF0782 has been shown to have a role in the 
expression of a phosphotransferase system (PTS) involved in sugar transport. Although a 
rpoN mutant was not isolated during our screen, deletion of EF0782 has been reported to lead 
to an increased resistance to autolysis (Iyer and Hancock, 2012). How RpoN affects AtlA 
activity remains unexplained. 
The strategy was the same for all genes (Fig. 57). Two homology regions (named H1 and H2, 
600 to 700 nucleotides each) were PCR amplified and fused together by PCR to create a 
deletion in the middle part of the candidate gene (Fig. 57). All PCR fragments corresponding 
to individual homology regions were successfully amplified (Fig. 57A) and fused (Fig. 57B). 
Several attempts were performed to clone these fragments in the thermosensitive plasmid 
pGhost9 either by Gibson assembly or conventional restriction cloning, but no positive clones 






Figure 57. Summary of the construction strategy of in-frame deletion (A), PCR strategy to 
amplify and fuse of homology regions. (B), Schematic representation of the fused homology regions 
(ca. 600 nucleotides each). (C), Recombinant plasmids for gene replacement. (D), PCR products 
corresponding to homology regions H1 and H2. (E), PCR products corresponding to the fusion of H1 
and H2 regions. (F), PCR screening of recombinant plasmids. Molecular weights in kbp are indicated 









3.3.2. Complementation experiments 
To confirm that the transposon insertion is responsible for the phenotype observed in the 
mutants isolated, we undertook complementation experiments to restore the phenotype of the 
parental strains. 
 
3.3.2.1. Construction of the complementation vectors for EF_0018, EF_0954 and EF_0782 
We first attempted to use plasmid pJEH11 (Fig. 58A), a shuttle expression vector that can 
replicate in both E. coli and E. faecalis (Bellais et al., 2006). 
pJEH11 contains a constitutive promoter and ribosome binding site and allows the expression 
of open reading frames (ORF) cloned as NcoI-BamHI fragments. It contains both 
spectinomycin (SpecR) and kanamycin (KmR) resistance markers that are used for the 
selection of the plasmid. We focused on the genes that we tried to delete (EF_0018, EF_0954 
and (EF_0782) rpoN the gene encoding σ54). 
Bsal and BamHI restriction sites were introduced into the 5’ and 3’ ends of EF0018 and NcoI 
and BamHI were introduced into the 5’ and 3’ ends of EF0954 and EF0782 by PCR (Fig. 
58B). PCR fragment (Fig. 58C) were purified and digested by NcoI and BamHI and cloned 
into pJEH11 similarly digested. Following transformation of E. coli with the ligation 
products, putative clones were screened by PCR but no positive clones could be identified 
could be (Fig. 58D). 
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Figure 58. Strategy for complementation expressing using pJETH. (A): Map of the plasmid used 
for complementation pJEH11. (B): Description of PCR strategy used to introduce restriction sites 
followed by amplification ORF. (C): PCR products corresponding to ORF. (D): PCR screening of 
putative recombinant pJEH11 clones using plasmid specific oligos Molecular weights in kbp are 
indicated on the left side of the gel. 
 
 
3.3.2.2. Construction of the complementation vectors for secA, secY and atlA mutants 
While we tried to complement the mutations from the transposon screen, we also attempted to 
complement the spontaneous mutants identified in (chapter 3.1.) using an alternative strategy. 
This time, we used the shuttle plasmid pTetH recently constructed in the laboratory. This 
replicative plasmid is a pAT18 derivative (Fig. 59). It contains: 
- A pAMβ1 origin of replication functional in E. faecalis; 
- An oriR origin of replication functional in E. coli; 
- A gene conferring resistance to Erythromycin in both E. coli and E. faecalis; 
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- A gene encoding the TetR repressor; 
- A promoter containing two operator sequences recognised by the TetR repressor and 
induced in the presence of anhydrotetracycline; 
- Two cloning sites (NcoI and BamHI) to clone an open reading frame fused to a 8-
Histidine C-terminal tag.  
 
Figure 59. Map of plasmid pTetH used as an inducible system for complementation experiments. 
The genes of interest for complementation experiments are cloned between the NcoI and BamHI sites 
to replace the open reading frame encoding E. faecalis Pbp5. 
 
The same cloning strategy (Gibson assembly) was applied for all target genes except for 
LysM, which is difficult to amplify by PCR due to the similarity of the binding modules. 
pTetH doubly digested by BamHI and NcoI (Fig. 60A) was used to clone the genes to 
complement. atlA, secA and  secY alleles were amplified using oligonucleotides AtlA_G_Rev 
and AtlA_G_Fw, SecA_G_Fw and SecA_G_Rev, SecY_G_Fw and SecY_G_Rev, 
respectively (Fig. 60B). Gibson assembly products were transformed into E. coli. Colonies 
resistant to erythromycin were chosen to extract DNA plasmids that were analysed by 
restriction using two enzymes on either side of the insert (EcoRI + SphI). All pTetH 
recombinant could be obtained except the one encoding the secA R70H allele (Fig. 60C). 
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   Template   Allele(s) to      Expected phenotype 
complementa 
secA 
 WT  JH2-2   R70H / DE377 / R548H        Longer chains 
 R70H  98, 11   WT       Shorter chains 
 DE377  2, 18, 23, 25  WT       Shorter chains 
 R548H  4   WT       Shorter chains 
secY 
 WT  JH2-2   L337S       Longer chains 
 L337S  0   atlA_E212Q      Shorter chains 
atlA 
 WT  JH2-2   DatlA       Shorter chains 
 E212Q  atlA_E212Q   WT / DatlA      Longer chains 
 LysM  JH2-2   WT / DatlA      Longer chains 
 
Table 7. Summary of the complementation experiments. 




The different steps of plasmid constructions are summarised in (Fig. 60). All pTetH 
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pTetH secA secY atlA













Figure 60. Construction of pTetH derivatives to complement the atlA, secA and secY mutants. 
(A), digestion of pTetH (n, native plasmid; B, BamHI; N, NcoI; B+N, BamHI + NcoI). (B), PCR 
amplification of secA, secY and atlA alleles used for Gibson assembly into pTetH digested by 
BamHI+NcoI: (1, secA_WT; 2, secA_R70H; 3, secA_DE377; 4, secA_R548H; 5, wild-type secY; 6, 
secY_L337S; 7, atlA_WT; 8, atlA_E212Q). (C), Restriction analysis of putative recombinant pTetH 
plasmids (1 and 2, pSecA_WT; 3 and 4, pSecA_DE377; 5 and 6, pSecA_R548H; 7, 8 and 9, 
pSecY_WT; 10 and 11, pSecY_L337S; 12, pAtlA_WT; 13, pAtlA_E212Q; 14, pAtlA_LysM). The 




3.3.3. Analysis of the AdmA protein 
To gain insights into the function of AdmA, we overexpressed the protein and purified it to 
determine its three dimensional structure using X-ray crystallography. The similarity to 
structures of proteins with known functions could suggest a function for AdmA. 
 
3.3.3.1. Expression of the recombinant AdmA protein 
The protein corresponding to residues 26 to 172 of AdmA was expressed as an N-terminally 
His-tagged protein in E. coli. A PCR product was amplified from chromosomal DNA using 
oligos introducing NcoI and BamHI sites at the 3’ and 5’ end of the fragment, respectively 
(Fig. 61A). The PCR product was digested by the two restriction enzymes and cloned into 
plasmid pET2817 similarly digested. After transformation of E. coli, most colonies screened 
by PCR with oligos on either side of the cloning site were positive (Fig. 61B). One of the 















Figure 61. Construction of the pET2817 derivative for recombinant AdmA expression. (A) PCR 
product of the fragment encoding residues 26-172. (B), PCR screening of putative recombinant 
pET2817 plasmsids using pET specific primers (pET_up and pET_dn). (C), Map of the pET-2817 
expressing AdmA. Molecular weights in kbp are indicated on the left side of the gel. 
 
 
3.3.3.2. IMAC purification of the recombinant AdmA  
AdmA overexpression was induced from a 1 L culture and expression of the protein was 
checked as described in sections 2.9.1 and 2.9.2. The soluble fraction was purified using 2 mL 
of Ni-Nta resin and the purification analysed by SDS-PAGE (Fig. 62). 
Approximately 10 mL of protein at 3.2 mg/mL was recovered from this first purification step. 
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Figure 62. Overexpression of recombinant AdmA in E. coli and IMAC purification. The SDS-
PAGE shows a comparison of crude extract (WC), soluble (Sol) and insoluble (P) fractions. After 
IMAC purification, the flow through (FT), wash (W) and eluted fractions (El) were loaded on a 15% 
SDS-PAGE. Molecular weights corresponding to the ladder are indicated in kDa on the left side The 




3.3.3.3. Size-exclusion purification of AdmA 
The eluted fractions from IMAC were filtered, loaded onto a Superdex 75 26/60 colunm pre-
equilibrated with buffer A (see 2.9.2) and eluted with an isocratic gradient at 3 mL/min (Fig. 
63). Six fractions 3 mL each corresponding to 14.5mg of protein were pooled and 
concentrated to 6 mg/mL on a 10kDa Amicon unit (Fisher Scientific). The concentrated 
























Figure 63. Size-exclusion purification of AdmA. (A), chromatogram of size-exclusion 
chromatography Fractions 15 to 19 (in red) were pooled. (B), an aliquot of each individual fraction 
were resuspended in loading buffer without reducing agent and 5 µg were loaded on a 15% SDS-
PAGE . Fractions 15 to 19 revealed the presence of two band of 17 and 35 kDa. (C), an aliquot of the 
pool corresponding to fractions 15 to 19 was resuspended in loading buffer containing 50 mM of DTT 
and 4 µg and 8 µg were loaded on a 15% SDS-PAGE. In reducing conditions, the higher molecular 
weight band disappeared, suggesting that it corresponds to an AdmA dimer. Molecular weights in kDa 
are indicated on the left side of the gel. 
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4. General discussion and future work 
Bioinformatic analyses suggest that the E. faecalis genome encodes at least 21 putative PG 
hydrolases. Only one of them (AtlA) has autolytic properties (Qin et al., 1998). AtlA plays a 
key role during cell division as it is dedicated to septum cleavage to allow the separation of 
daughter cells (Mesnage et al., 2008). Recent work in the laboratory has shown that although 
AtlA activity is not essential, it is necessary for E. faecalis pathogenesis in the zebrafish 
model of infection (B. Salamaga and S. Mesnage, unpublished). Formation of long chains 
increases uptake by phagocytes which severely impairs the virulence of E. faecalis. Given the  
 key role of AtlA during growth and division, its potential suicidal activity and its contribution 
to pathogenesis, we sought to explore the mechanisms controlling AtlA activity. 
 
4.1. Two complementary strategies provide distinct insights into the mechanisms 
underpinning AtlA activity 
We used two approaches to isolate either spontaneous or transposon mutants with altered 
AtlA activity. In both cases, mutants with septum cleavage defects had mutations in the atlA 
gene itself. Only one gene required for optimal septum cleavage (admA) was found using both 
methods. Unlike transposon mutagenesis, which allows the identification of loss-of-function 
mutations, spontaneous mutants mostly had single nucleotide polymorphism generating 
missense or nonsense mutations (amino acid substitutions and premature stop codons). 
One mutation corresponded to a single amino acid deletion. Apart from admA, distinct sets of 
genes were identified using the two mutagenesis strategies. This result indicated that 
combining two types of screens expands the range of mutations identified and allowed 
identifying the contribution of essential genes such as secY and secA to the septum cleavage 
mechanism.  
 
4.2. The control of AtlA activity involves a multitude of mechanisms, allowing both 
spatial and temporal control of activity 
 
4.2.1. AtlA post-translational modifications modulate enzymatic activity 
Recent data from the host laboratory indicate that the N-terminal domain of AtlA is the target 
of post-translational modifications: glycosylation and proteolytic cleavage by extracellular 
proteases (A. Jareño and S. Mesnage, unpublished). 
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The glycosylation occurring on the N-terminal region of AtlA exacerbates the inhibitory role 
of this domain, most likely by steric hindrance, preventing the catalytic site of the enzyme to 
access its substrate. Two major proteases are secreted by E. faecalis: the metalloprotease GelE 
and the serine protease SprE. In the absence of GelE, cells form longer cell chains (Waters et 
al., 2003), suggesting that this enzyme is capable of cleaving AtlA. GelE-mediated cleavage, 
likely to result in the truncation of the N-terminal domain, would ensure that the enzyme is 
only fully active once translocated at the cell surface where it will be able to cleave its 
substrate, peptidoglycan. Although mutations in GelE are expected to reduce the activity of 
AtlA, we did not identify any gelE mutant in our screens. It is also worth mentioning that 
several E. faecalis strains do not produce GelE (such JH2-2 that we used to isolate 
spontaneous mutants). It is tempting to assume that other proteases can cleave the N-terminal 
domains during growth. Whether the gene we identified annotated as an endopeptidase (see 
table 6) is involved in this process remain to be established. 
 
4.2.2. AtlA targeting to the division site prevents septum cleavage by other PGHs 
Most mutations suppressing the long chain phenotype of the strain expressing a catalytically 
inactive AtlA (AtlAE212Q-GFP) are predicted to abolish AtlA production or PG binding. This 
result indicated that other PGHs are able to access the septum and to cleave it in the absence 
of AtlA. This has already been proposed for AtlB and AtlC, which have a weak septum 
cleavage activity that can only be detected in the absence of AtlA (Mesnage et al., 2008). 
 
The reason why AtlA is so efficient at cleaving the septum awaits further analysis. Several 
possibilities (non-mutually exclusive) have to be considered: (i) AtlA could be produced in 
larger amounts; (ii) AtlA could bind peptidoglycan with a higher affinity than other PGHs; it 
is worth pointing out that the AtlA LysM domain has 6 imperfect repeats, whereas all other 11 
E. faecalis LysM proteins have only one or two LysM repeats; (iii) AtlA is preferentially 
targeted to the septum; (iv) the structure of PG at the septum is preferentially recognised and 
cleaved by AtlA. In this case, both the PG binding activity of AtlA and its catalytic activity 
could be involved. Recent work suggests that in E. coli, the PG at the septum is enriched in 
denuded glycan chains generated by an amidase activity (Yahashiri et al., 2015). Interestingly, 
LysM domains bind to chitooligosaccharides (GlcNAc5-6) more rapidly than they bind to PG 
fragments (Mesnage et al., 2014). 
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If E. faecalis PG is also enriched in denuded glycan chains, it is t possible that AtlA LysM 
domain will preferentially bind to this site. Whether glycan chains without a peptide stem are 
better substrates for the catalytic domain is currently being investigated in the laboratory. 
 
4.2.3. admA is a novel gene required for the septum cleavage activity of AtlA 
The host laboratory has shown that AtlA localisation is restricted to the septum (B. Salamaga 
and S. Mesnage, unpublished). Some of the results presented in this work provide some 
information on the mechanism underpinning this localisation, but also raise several questions. 
admA was identified independently in our two screens, strongly suggesting that this gene is a 
key player for AtlA optimal activity. A mutation in admA does not abolish the activity of 
AtlA but decreases the proportion of enzyme exposed at the cell surface. Zymogram analyses 
suggest a defect in translocation as indicated by an increased amount of pre-protein in crude 
extracts (Fig. 44). 
Fluorescence microscopy confirmed that in the admA mutant, AtlA is sequestered inside the 
cell, either associated with the membrane or in the cytoplasm. How AdmA contributes to 
AtlA surface display is puzzling. A tempting hypothesis is that AdmA interacts directly with 
AtlA to recruit it at the septum where it is secreted. If this is the case, the septal localisation of 
AdmA itself at the septum remains to be elucidated. Another possibility is an indirect role of 
AdmA in AtlA subcellular localisation. Topological and structural predictions suggest that 
AdmA is a membrane-anchored cytoplasmic protein with polysaccharide N-deacetylase 
activity. In this case, two possible substrates can be proposed: AtlA itself, which is very likely 
to be modified by GlcNAc residues (Rolain et al., 2013) or the rhamnopolysaccharide Epa 
cytoplasmic precursors (not peptidoglycan, which does not contain any deacetylated sugars in 
E. faecalis). The first hypothesis implies that the de-acetylation of AtlA glycosyl residues is 
required for optimal secretion. 
An expected consequence is that the lack of glycosylation should suppress the long chain 
phenotype of the admA mutant. The construction of the double gtfAB admA mutant could test 
this hypothesis. The second hypothesis (AdmA deacetylates Epa precursors) is difficult to 
connect to a mis-localisation of AtlA unless we imagine that LysM domains are recruited by 
GlcNAc residues from Epa precursors. In this case, one has to imagine that the synthesis of 
Epa, occurring at the septum is a key step to bring AtlA in the vicinity of the secretion 
apparatus, also preferentially located at the septum. 
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This model is plausible but very speculative. Several experiments to gain insights into the 
localisation of SecY, SecA or the Epa biosynthetic machinery would be required to further 
test this hypothesis. 
 
4.2.4. Secretion of AtlA as a mechanism controlling its activity 
 Our phenotypic screen led to the identification of mutations in secA and secY associated with 
the formation of shorter cell chains. These mutations, clustering around the SecY channel 
entrance are reminiscent of the prl mutations described in E coli secY. prl mutations have 
been proposed to destabilise the closed state of the secretion channel or stabilize the open 
form, thus allowing secretion of proteins without prior binding to the signal peptide as a 
triggering event (Smith et al., 2005). 
By analogy, it is tempting to assume that the mutants we isolated allow an increased secretion 
of surface proteins including some that contribute to cleave the septum. The identification of 
the proteins affected by the mutations identified remains to be identified. Another question 
that awaits further investigations is the mechanism of AtlA secretion. Unlike the N-
acetylmuramidase AtlB which has a 21 residues-long signal peptide, AtlA secretion signal is 
unusually long (53 residues). Interestingly, such extended signal peptides (ESP) have only 
been reported in Gram-negative bacteria so far (Desvaux et al., 2007). It has been proposed 
that ESPs mediate post-translational translocation across the cytoplasmic membrane. Their 
presence severely delays inner membrane translocation, but the mechanism responsible for 
this delay is unclear. It has been proposed that they could adopt a particular conformation or 
mediate interactions with a cytoplasmic or inner membrane co-factor, prior to inner 
membrane translocation (Peterson et al., 2006). Slowing down the surface translocation of 
AtlA could create a temporal control of AtlA activity as this enzyme has to cleave the septum 
towards the end of cell division, once the septum is fully formed. 
 
4.2.5. Impact of carbohydrate metabolism on AtlA activity 
Several genes identified in our transposon mutant screen were involved in carbohydrate 
metabolism, suggesting that cell surface polymers have an impact on the activity of AtlA. The 
modification of PG associated-polysaccharides is expected to modulate AtlA activity by 
several potential mechanisms: 
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 (i) steric hindrance that could prevent binding and/or catalytic activity; (ii) modification of 
the cell wall charge that could impair binding of the AtlA LysM domain or (iii) an indirect 
impact on AtlA resulting from inhibition/alterations in PG synthesis. It is tempting to assume 
that the regulatory network controlling carbohydrate metabolism is under the control of the 
master regulator σ54 (RpoN). 
E. faecalis has been linked to the transcriptional control of PTS systems including EF_0020 
that we identified in our screen, via EF_0018. The link between RpoN and autolysis and the 
release of extracellular DNA has been clearly established (Iyer and Hancock, 2012). 
Surprisingly, although rpoN deletion inhibits autolysis, this mutation has no impact on AtlA 
activity detected by zymogram using M. luteus as a substrate (Iyer and Hancock, 2012). One 
possibility is that rpoN mutation has no impact on AtlA itself, but instead leads to 
modification of the cell wall properties . Zymogram experiments should be carried out using 
rpoN cells as a substrate to test this hypothesis.  
 
4.3. Future experiments and perspectives 
This study represents the first step towards understanding the regulation of AtlA-mediated 
septum cleavage. Due to time constraints, several key experiments could not be completed to 
confirm the impact of the mutations identified on AtlA activity. The priority will be to carry 
out complementation experiments using the plasmids already constructed towards the end of 
this work in the pTetH vector (for atlA, secA and secY); as for admA, a complementation 
vector has been provided by S. Kulakauskas (INRA, Jouy-en-Josas). pTetH derivatives also 
need to be constructed to confirm that the transposon insertions are responsible for the chain 
forming phenotypes observed. Once the complementation experiments have been carried out, 
we will have to answer the following questions: 
- How do surface carbohydrates modulate AtlA activity? 
A simple experiment will be to measure the activity of recombinant AtlA on mutant cell walls 
and PG. To do this, the specific activity of AtlA could be measured using a turbidity assay in 
vitro. A more relevant assay will be the septum cleavage assay that specifically measures the 
cleavage of septal PG by AtlA. The next step will be to establish the role of the genes 
identified in carbohydrate biosynthesis: do they alter the amount of surface polysaccharides 
produced by E. faecalis and/or their composition? This will involve the extraction of surface 
polysaccharides from WT and mutant strains and their analysis using NMR or gas 
chromatography. 
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- How does AdmA contribute to the septal localization of AtlA? 
Recent experiments in the lab revealed that AtlA is no longer localised at the septum in the 
admA mutant, but instead found in the cytoplasm. As a first step, we need to test a direct 
interaction between AtlA and AdmA, which could directly recruit this autolysin to the 
septum. The access to purified enzyme (see paragraph 3.3.3.) will allow testing this 
hypothesis using biophysical methods such as microscale thermophoresis or isothermal 
calorimetry available in the department. If these results do not show any interaction between 
recombinant proteins, we will have to consider an indirect role of AdmA in AtlA localisation 
and we will therefore need to explore other possibilities. For example, we could try to identify 
AdmA partners that in turn could recruit AtlA directly. This could be achieved using co-
purification experiments. Finally, based on the topology and structure predictions, we could 
also explore the contribution of AdmA in the production of surface polymers using the 
strategies mentioned above. Crystallisation trails are currently in process. Determining the 
structure of AdmA may provide insights into the role of this protein. 
- Does AtlA secretion contribute to the functional specialisation of this enzyme? 
We identified several sec mutations associated with a modification of the chain forming 
phenotype. At this stage, we do not know if these mutations alter the secretion of AtlA only, 
all secreted proteins except AtlA or all secreted proteins. To answer this question, we need to 
carry out proteomics experiments to compare the proteins secreted by the WT and mutant 
strains. We could compare surface proteins (using 8M urea to recover all non-covalently 
bound surface proteins) and secreted proteins in supernatants. Alternatively, we could use the 
pTetH derivative expressing a His-tagged AtlA to follow its secretion rate in WT and sec 
mutant genetic backgrounds. The outcome of these experiments may provide information 
concerning the specific recognition of signal peptides from secreted proteins by the Sec 
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